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ABSTRACT

THE BRAZILIAN-PORTUGUESE MCMI-III:
DIAGNOSTIC VALIDITY OF THE ALCOHOL DEPENDENCE AND
DRUG DEPENDENCE SCALES
by
Cristina Lílian Magalhães
Nova Southeastern University

The Brazilian-Portuguese Millon Clinical Multiaxial Inventory-III (BP-MCMIIII) is a newly developed translation of the original MCMI-III and requires validation
before it can be used in cross-cultural research and clinical settings. This study was the
first validation study with the BP-MCMI-III and examined the validity of its Alcohol
Dependence and Drug Dependence scales for identifying substance-related disorders in a
Brazilian sample.
The diagnostic validity of these scales was examined by comparing participants’
scores on the BP-MCMI-III against group status (controls versus patients receiving
substance abuse treatment) and against clinical diagnoses made based on a DSM-IV-TR
symptom checklist. In addition, diagnostic validity statistics were also computed for both
scales. The construct validity of the Alcohol Dependence scale was examined by
comparing the subjects’ scores with their performance on a Brazilian version of the
Alcohol Use Disorders Identification Test (AUDIT).
The total sample used in this study consisted of 126 Brazilians residing in the
metropolitan area of Rio de Janeiro, Brazil. Of the total sample, 75 were inpatients at
treatment facilities for substance abuse and 51 were not receiving treatment for alcohol-
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or drug-related problems at the time of testing. The results of this study supported the
validity of the BP-MCMI-III for diagnosing substance-related disorders among
Brazilians.
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CHAPTER I
Statement of the Problem
A Brazilian-Portuguese version of the Millon Clinical Multiaxial Inventory-III
(BP-MCMI-III) was developed to be used in future studies that will examine crosscultural aspects of personality and psychopathology in Brazil and the United States. The
initial phases of this project were conducted by this researcher and her associates, and
involved the completion of four preliminary steps in cross-cultural test adaptation: (1) the
translation phase, which included a series of procedures used to maximize translation
accuracy and readability; (2) a pilot test-retest study, which evaluated item equivalency
using a bilingual sample; (3) the revision phase, which involved further refinement of
problem-items; and (4) a preliminary reliability study, which evaluated the psychometric
properties of the new version with data collected in Brazil. The results of these studies
were encouraging and suggested that the translated instrument is psychometrically
reliable and comparable to the original MCMI-III. Stability coefficients for all scales
were above .6 and significant at .001 level with the Brazilian sample. The methodological
procedures for the translation, as well as the results of the bilingual test-retest and the
preliminary reliability study, were summarized in two unpublished manuscripts
(Magalhaes, Magalhaes, Sellers & Lewis, 1999; Magalhaes, Magalhaes, Sellers, Lewis,
Cruz, & Corga, 2004). See Appendices A and B.
Although test translations used in research and clinical practice are often developed
in casual and unsystematic ways, the literature offers several guidelines for developing
quality translations; that is, translations that retain comparable item content and
psychometric properties with the original instrument and assess the constructs of interest

4
with the same or similar degree of accuracy (Bracken & Barona, 1991; Geisinger, 1994;
Butcher, 1996a; Butcher, 1996b; Butcher & Hans, 1996; Sperber, Devellis, & Boehlecke,
1994; Van de Vijver, F., & Hambleton, R. K., 1996). Suggested procedures include not
only a multistep translation process, like the one described above for the BP-MCMI-III, but
also a series of validation studies that can offer support for the usefulness of the translated
instrument for assessing constructs of interest in the target population. The argument is that
even if the test itself remains unchanged after being translated (linguistically and
psychometrically speaking), there is no guarantee that it assesses the same construct in a
different culture or that the new version continues to provide scores that can be interpreted
in the same manner it was proposed for the original version.
To date no validation studies have been conducted to evaluate the usefulness of the
BP-MCMI-III for assessing psychopathology in the Brazilian population. The BP-MCMIIII, like the original MCMI-III, has a total of 27 subscales: (a) 3 for estimating the
individual’s test-taking attitude, (b) 14 for measuring different personality styles, and (c) 10
for assessing the presence of clinical syndromes (Millon, 1997). Because the BP-MCMI-III
is expected to measure several constructs at the same time, its validation is clearly a
complex task and requires a systematic approach.
The validity studies reported in the MCMI-III manual involved the participation of
several clinicians who administered the test on their own clients. These clinicians then rated
the presence or absence of various personality traits and symptoms of clinical syndromes for
each client based on their knowledge of Millon’s theory of personality and psychopathology
and the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders criteria
(DSM-IV; American Psychiatric Association, 1994). Familiarity with Millon’s theory
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was considered to be an important characteristic of the raters because some personality
patterns assessed by the instrument can not be easily identified using the DSM-IV criteria
only. The following is a section included in the Rating Reference Booklet provided to
participating clinicians:
“Our view here is that personality is not expressed only in the cognitive,
or behavioral, or psychodynamic, or interpersonal realms, but is instead
manifested across all of these clinical domains, and that the DSM is
markedly incomplete with regard to its sampling of many domains of
clinical expression. You should attempt to use both DSM and Millon
criteria when making your personality rating decisions.” (Millon, 1997, p.
90).
Since the use of raters trained on Millon’s theoretical approach was not feasible at
this time, this investigator selected two clinical syndrome scales – the Alcohol Dependence
and Drug Dependence scales – to be the focus of this study. Unlike the personality scales,
the MCMI-III clinical syndrome scales were expected to correspond more directly to the
current diagnostic nomenclature with which most clinicians and researchers are familiar –
the DSM-IV-TR. Diagnosis made based on DSM-IV-TR criteria could then serve as a “gold
standard” to which diagnosis made based on the MCMI-III could be compared.
The decision to select the substance dependence scales for this study, among other
clinical syndrome scales, was based primarily on this investigator’s clinical interest in the
field of substance abuse and on the relative ease of gathering clinical data on this clinical
population. Although several instruments for assessing alcohol and drug use are available,
the MCMI-III is unique in that it provides the opportunity for assessing addictive behaviors
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in the context of personality styles and general psychopathology. The results of this study
will provide relevant information regarding the validity of the BP-MCMI-III for assessing
substance use problems in the Brazilian population.
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CHAPTER II
Review of the Literature
Principles of Test Validation
The validity of a test is defined simply as an estimate of how well the test
measures what it is supposed to measure. Thus, procedures for determining validity
typically involve ways of understanding the relationship between a subject’s performance
on the test and his performance on some other measure or measures of the same
characteristic (the criterion) being studied.
The literature describes several types of validity and several methods for
estimating validity. A common procedure, content validation, involves evaluating the
extent a test measures a representative sample of all characteristics of the domain being
assessed. Although content validity is expected to be built into a test from its
development (through the choice of appropriate items), it can never be assumed. Potential
threats to content validity include the following: (a) test items may not cover all major
aspects of the domain being assessed, (b) test items may cover all aspects but not in the
correct proportions, or (c) some items may be irrelevant. Procedures to ensure content
validity are usually fairly simple. They involve consultations with experts who provide
information on the importance of specific characteristics that need to be assessed with the
test and a systematic examination of the test items to see if they cover all relevant aspects
identified by the experts (Anastasi & Urbina, 1997).
Content validity is considered to be of major importance for evaluating the
usefulness of tests that measure a person’s skill or knowledge of a certain topic, such as
with achievement tests. However, Anastasi and Urbina (1997) stated that content
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validation alone is usually inappropriate, or even misleading, for personality tests due to
the fact that these tests may not necessarily bear any resemblance to the behavior domain
they hope to sample. Because personality tests are typically developed based on a
researcher’s theory, it may be impossible, just by looking at the content of the items, to
determine what is really being measured. Thus, in the case of personality inventories such
as the BP-MCMI-III, construct-identification procedures are considered to be of greater
relevance.
Construct validity refers to the extent a test appropriately measures a construct or
a trait that is theoretically defined and typically involves the gradual accumulation of
evidence from a variety of sources. Because any given psychological construct can be
operationalized in various ways, different gauges (single test items) can be created, each
assessing different aspects of the construct and none fully capturing the almost infinite
number of descriptive variables associated with that construct. For example, alcohol
dependence can be measured directly or indirectly (depending on how it is theoretically
defined) by assessing frequency of drinking days, amount of alcohol consumed on a
typical drinking day, frequency and severity of relationship problems caused by drinking,
amount of time spent drinking, frequency of impulsive behavior in various situations,
ability to effectively cope with stressful situations, or level of occupational functioning,
just to name a few associated variables. Given that psychological constructs are complex
theoretical entities, it is reasonable then to expect that any single study aiming at
establishing construct validity of an instrument must fail to fully capture its multifaceted
nature (Davis, Wenger & Guzman, 1997). Correlations with other tests (criterion
measures), factor analysis, internal consistency, convergent and discriminant validation,
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and structural equation modeling procedures are some of the methods usually employed
to evaluate construct validity (Anastasi & Urbina, 1997; Millon, 1997).
Another type of validity, criterion-predictive validity, refers to how well a
subject’s performance on a test predicts his performance in the future in some other
measure. Although this method is especially appropriate for tests used in the selection of
individuals for jobs or educational programs (e.g., predicting how well a person would
perform certain tasks at a new job), it may also be used to predict clinical outcome; for
example, to evaluate an individual’s probability of benefiting from one form of treatment
versus another. A broader definition of criterion-predictive validity can also include
evaluating how well a test can predict a person’s performance on another measure that is
administered concurrently or predict the person’s inclusion on a particular category (e.g.,
a diagnosis), in which case the time factor (predicting into the future) would not be
relevant (Anastasi & Urbina, 1997).
Diagnostic Validity Indices
A special form of predictive validity, diagnostic validity, is considered to be an
important characteristic of a diagnostic tool such as the MCMI and will be the primary
focus of this proposed study. The diagnostic validity or efficiency of a test is typically
measured in terms of the test’s operating characteristics, which include prevalence,
sensitivity, specificity, positive predictive power, negative predictive power, and overall
diagnostic power (Retzlaff, 1996; Retzlaff & Gibertini, 1994).
Prevalence is estimated based on a particular sample composition and is
calculated by dividing all disordered cases (true and false positives) by the number of
subjects in the sample. For practical purposes, prevalence refers to the probability that a
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particular person has the disorder the test measures before any further information is
known.
Sensitivity refers to how well a diagnostic instrument detects a particular disorder
or a cluster of symptoms; in other words, how sensitive a test is in the presence of the
disorder. Sensitivity is calculated by dividing the number of cases identified by the test as
having a disorder (test positives) by the total number of cases having the disorder
(including true positive cases not identified by the test). Although considered a very
important operating characteristic, sensitivity alone tells us very little about the validity
of a diagnostic instrument. For example, a test can be highly sensitive (able to identify
100 percent of true positive cases in a particular sample) and, at the same time,
misdiagnose several cases, finding pathology when it does not exist (false positives).
Specificity, on the other hand, refers to the degree to which a test detects a specific
disorder and excludes other pathologies; that is, whether the test is specific enough to
identify as positive those cases that truly have the disorder. Specificity is calculated by
dividing the number of cases not identified by the test as having the disorder (including
true and false positives) by the total number of true negative cases. Thus, if we frame the
operating characteristics of a test in terms of conditional probabilities, specificity can be
defined as the probability that the test is negative given the disorder is absent, whereas
sensitivity would be the probability that the test is positive given the disorder is present
(Gilbertini, Brandenburg, & Retzlaff, 1986).
Specificity and sensitivity are usually considered to be independent of the
prevalence of the disorder in the sample; in other words, a test should identify the same
proportion of disordered cases across samples. However, calculating these two indices
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requires that one knows which cases in the sample really have the disorder the instrument
is supposed to detect. Therefore, sensitivities and specificities are dependent on the
accurate classification of subjects into appropriate diagnostic categories.
Positive predictive power (PPP) is defined as the proportion of positive cases that
actually have a disorder and it is equal to the number of true positives divided by the
number of test positives. Negative predictive power (NPP) is the proportion of
individuals identified as negative cases that in fact do not have the disorder. This index is
calculated by dividing true negatives by test negatives. Both predictive power indices are
influenced by the prevalence of the disorder in the population and the magnitude of the
sensitivity and specificity of the test. Generally speaking, these indices are optimal when
sensitivity and specificity are above 90%. However, even a very good test (a test with
high sensitivity and high specificity) loses positive predictive power when prevalence
falls below 10% (Gilbertini, Brandenburg, & Retzlaff, 1986). In addition, in the absence
of good specificity, positive predictive power and sensitivity tend to be inversely related.
That is, when the sensitivity of an instrument increases, false positives increase, and
positive predictive power declines (Millon, 1997).
Compared to specificity and sensitivity, predictive power indices are considered
more useful to the practitioner making decisions about individual patients but are often
not reported in test manuals because the data necessary to determine them is rarely
collected. According to Gilbertini, Brandenburg, and Retzlaff (1986), “the following are
needed: (a) an empirically based estimate of the prevalence of the disorder in the
population on which the test will be used, (b) the valid assignment of patients to
diagnostic categories, and (c) an independent administration of the test to the selected
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sample.” The assignment of sample patients to groups (criterion b) can also serve as the
estimation procedure for population prevalence (criterion a), but the administration of the
test under consideration must be conducted independently from the assignment process
(criterion c).
Lastly, overall diagnostic power (DxP) is a global index of a test’s overall
classification accuracy. Generally speaking, this index is a combination of the two
predictive power indices and reflects the proportion of correctly classified subjects
according to the presence or absence of a disorder. Although often reported in test
manuals, high overall diagnostic power can be very misleading because it is possible to
have a high overall diagnostic power even when the number of false positives and false
negatives are greater than the number of true positives, especially when the prevalence of
the disorder is low (Gilbertini, Brandenburg, and Retzlaff, 1986).
Although used less frequently in the MCMI literature, five additional measures of
diagnostic validity should also be discussed in this section. These are the Incremental
Validity of Positive Test Diagnoses, the Incremental validity of Negative Test Diagnoses
(INPP), Cohen’s Kappa, Cohen’s Effect Size, and Area Under ROC Curves.
The Incremental Validity of Positive Test Diagnoses (IPPP) is the difference
between a scale’s positive predictive power and the prevalence of the disorder in the
sample. Even though some experts in the field have emphasized the importance of
positive predictive power over other validity measures (Retzlaff, 1996; Millon, 1997),
Hsu (2002) pointed out that this diagnostic index has some limitations and should be
interpreted with caution. His argument is that in the absence of any correlation between
test scores and a disorder, positive predictive power is expected to be equal to prevalence
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(Gibertini et al., 1986; Kraemer, Kazdin, Offord, Kessler, Jensen, & Kupfer, 1999; both
cited in Hsu, 2002). Thus, one can say that diagnoses made by the test are preferable to
diagnoses assigned randomly only when positive predictive power is greater than
prevalence. IPPP then provides a measure of how much better than chance a test makes a
diagnosis. IPPP values range from zero to plus or minus 1.0, with zero indicating that
test-based positive diagnoses are equal to chance and the maximum value of 1.0
indicating that the test produces no diagnostic errors. Negative values indicate that testbased classifications are worse than chance.
Similarly to IPPP, the Incremental Validity of Negative Test Diagnoses (INPP)
provides a measure of how much better than chance a test correctly identifies cases
without the disorder; and it is defined as the difference between a scale’s negative
predictive power and the prevalence rate of patients not having the disorder. INPP values
also range from zero to plus or minus 1.0, with zero indicating that test-based negative
diagnoses are equal to chance and 1.0 indicating that the test is 100 percent valid in
detecting no pathology. Negative values indicate that test-based classifications are worse
than chance (Retzlaff, 2000; Hsu, 2002).
Although best known as a measure of interrater agreement, Cohen’s Kappa can
also be used as a measure of the combined incremental validities of positive and negative
test diagnoses (IPPP and INPP) relative to random assignment of diagnoses. That is, it
can compare the proportion of correct positive and negative test-based diagnoses to the
proportion of correct positive and negative diagnoses made by chance. Similarly to IPPP
and INPP, maximum value of Cohen’s Kappa is 1.0. Negative values indicate that testbased diagnoses are worse than chance, zero indicates it is equal to chance, and 1.0
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indicates that diagnoses (positive and negative) are 100 percent accurate (Hsu, 2002;
Huck, 2000).
It should be noted that Cohen’s Kappa, predictive power indices (PPP and NPP),
and incremental validities of positive and negative test diagnoses (IPPP and INPP) are
affected by prevalence and base rates. Thus, values for these diagnostic validity measures
tend to vary greatly depending on the characteristics of the sample used to derive data.
Cohen’s Effect Size (d) is independent from prevalence and base rates, and can serve as a
measure of the relative ability of a test to discriminate between groups.
Lastly, the Area Under ROC (receiver operating characteristic) Curves, also
known as AUC, has been recently recognized in the literature as another measure of
diagnostic validity that is free from the effects of prevalence and cut-scores. ROC
analysis is part of a field called "Signal Detection Theory" and was originally developed
during World War II for the analysis of radar images (Tape, 2004). Advantages of AUC
are its simplicity and generalizability (McGraw & Wong, 1992; cited in Hsu, 2002). Both
Cohen’s (d) and AUC are considered robust to moderate violations of the normality and
homogeneity of variance assumptions (Hanley, 1988; McFall & Treat, 1999; McGraw &
Wong, 1992; cited in Hsu, 2002).
Validation of the MCMI Substance Dependence Scales
This section will review the methodological procedures and research findings that
support the validity of the substance dependence scales for the three generations of the
MCMI. The reason for discussing the three MCMI versions, rather than simply focusing
on the latest, is that, according to Millon (1997), validity of each newer version is largely
supported by the validity of the previous.
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Content Validity
According to Millon (1997), validation of the MCMIs was accomplished in three
stages. The first stage, theoretical-substantive, addressed content validity, by examining
the extent the items that make up the various scales derived their content from Millon’s
theory of personality and his definitions of clinical syndromes (Millon, 1981). The
Alcohol Dependence scale was designed to detect individuals who have a history of
alcoholism, had tried to overcome the problem with minimal success, and are
experiencing difficulties in the family and work setting as a result of drinking. Similarly,
the Drug Dependence scale was designed to detect individuals with recurrent or recent
histories of drug abuse, who are finding it difficult to restrain their impulses to use/abuse
drugs, and are unable to manage the consequences of their behavior. Many subtle and
indirect items were included in both scales in an attempt to identify individuals who were
not ready to admit their substance use problems. Millon’s rationale for including these
scales in the MCMI was to provide the opportunity for studying an individual’s substance
use problems in the context of his overall personality style (Millon, 1997).
Reliability
The second validation stage, internal-structural, first examined the internal
consistency of the various scales and selected the items that maximized scale
homogeneity. Each scale was expected to have a high degree of internal consistency,
display a considerable overlap with some of the other scales, and demonstrate satisfactory
levels of endorsement frequency and reliability over time. In the case of the MCMI-III, a
research form was initially developed, consisting of the 175 items from the MCMI-II and
150 new items, which together made up a larger item pool from which item selection for
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the MCMI-III was made. Endorsement rates for each of the 325 items were examined to
ensure that it fell within an acceptable range, and items with very high or very low
endorsement frequencies were eliminated. Several statistics were then computed and
recomputed simultaneously as items were added or removed from their respective scales.
This process allowed for the identification of the best item composition for each scale
based on statistical and substantive criteria. Chronbach’s alphas (N = 398) and test-retest
correlation coefficients (N = 87) were calculated for the resulting scales, which now
comprise the MCMI-III. The Chronbach’s alphas obtained for the Alcohol and Drug
Dependence scales were .82 and .83, respectively. Test-retest reliability coefficients for
these scales were .92 and .91. Table 1 presents the results for all scales.

17
Table 1
Length, Internal Consistency, and Test-Retest Reliability of the MCMI-III Scales

Clinical Personality Patterns
1
Schizoid
2A
Avoidant
2B
Depressive
3
Dependent
4
Histrionic
5
Narcissistic
6A
Antisocial
6B
Sadistic (Aggressive)
7
Compulsive
8A
Negativistic
8B
Masochistic
Severe Personality Pathology
S
Schizotypal
C
Borderline
P
Paranoid
Clinical Syndromes
A
Anxiety
H
Somatoform
N
Bipolar: Manic
D
Dysthymia
B
Alcohol Dependence
T
Drug Dependence
R
Post-Traumatic Stress Disorder
Severe Clinical Syndromes
SS
Thought Disorder
CC
Major Depression
PP
Delusional Disorder
Modifying Indices
X
Disclosure
Y
Desirability
Z
Debasement

Number
of Items

Internal
Consistencya

Test-Retest
Reliabilityb

16
16
15
16
17
24
17
20
17
16
15

.81
.89
.89
.85
.81
.67
.77
.79
.66
.83
.87

.89
.89
.93
.89
.91
.89
.93
.88
.92
.89
.91

16
16
17

.85
.85
.84

.87
.93
.85

14
12
13
14
15
14
16

.86
.86
.71
.88
.82
.83
.89

.84
.96
.93
.91
.92
.91
.94

17
17
13

.87
.90
.79

.92
.95
.86

NA
21
33

NA
.86
.95

.94
.92
.82

a

Cross-Validation Sample (N = 398)
Test-Restest Interval = 5-14 days (N = 87)

b

Base Rate Development
Unlike most tests, the MCMI uses Base Rate (BR) scores, instead of T scores, to
transform raw data into interpretable information. Created through criterion referencing
(not norm referencing), BR scores are anchored to the prevalence rate of personality
characteristics and clinical syndromes in the psychiatric population. Consistent with
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Millon’s theory of personality, the MCMI assumes that the difference between a clinical
disorder and normal functioning is a matter of degree rather than kind; that is, traits and
symptoms are viewed in a continuum (Millon, 1981; Millon, 1997).
Base Rate development was completed also during the internal-structural stage of
the test’s validation process. First, the target prevalence of each of the characteristics
represented by 24 clinical scales were established “by calculating the proportion of times
clinicians rated each trait as a client’s most prominent problem (the prominent prevalence
rate) or as present but not as prominent as the first (the present prevalence rate)” (Millon,
1997; pg. 60). For the 11 scales measuring clinical personality patterns, two additional
prevalence rates were calculated: the trait prevalence rate, indicating the proportion of
time clinicians rated each personality pattern as a trait; and the disorder prevalence rate,
indicating the proportion of time personality patterns were rated as disorders. These
prevalence rates were then adjusted based on results of various epidemiological studies to
develop the final criteria used to create the BR scores. The anchoring of BR scores was
accomplished by determining the equivalence of a BR score of 0 to a raw score of 0, a
BR of 60 to the median raw score, and a BR of 115 to the maximum attained raw score.
Cut-off scores were determined as follows: scores of 75 and above indicate the presence
of a trait or clinical syndrome; while scores of 85 and above indicate the presence of a
disorder or prominence of a syndrome. Table 2 shows BR transformations for the
Alcohol Dependence (B) and Drug Dependence (T) Scales.
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Table 2
BR Transformations for the Alcohol Dependence (B) and Drug Dependence (T) Scalesa
BR Scale Scores
Raw
Score
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
a

Males
B
0
15
30
45
60
65
70
75
77
79
81
83
85
88
92
95
98
102
105
108
112
115

Females
T
0
15
30
45
60
62
63
65
67
68
70
72
73
75
78
82
85
92
98
104
110

B
0
25
60
61
62
63
64
68
70
71
75
78
80
82
85
90
95
100
105
110
115
115

T
0
25
60
62
63
64
65
66
67
68
70
75
80
85
91
97
103
109
115
115
115

Millon (1997).

Diagnostic Validity of the original MCMI
Evidence of the MCMI value as a diagnostic tool was gathered in the third and
final validation stage – the external-criterion stage. The diagnostic validity of the first
MCMI was estimated based on a study with 978 psychiatric patients with mixed
diagnoses. According to Millon (1983), the results of this study indicated that the Alcohol
Abuse and Drug Abuse scales were effective in detecting individuals with substance
abuse histories. McMahon, Flynn, and Davidson (1985), in a study involving repeated
administrations of the MCMI throughout treatment, found that scores on the substance
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abuse scales in fact remained significantly elevated over time (whereas other scales were
less stable), indicating that the MCMI was able to detect the subjects’ substance abuse
histories independent of current use.
While the Alcohol Abuse and Drug Abuse scales were found to be generally
elevated among substance abuse patients in some studies (Flynn & McMahon, 1984;
Stark & Campbell, 1988; McMahon, Flynn, and Davidson, 1985), other investigators
questioned the MCMI substance abuse scales’ diagnostic value and raised concern about
the content of the scale items and the independence of these scales. In a study with 561
psychiatric inpatients, using the standard base-rate cutoff score of 75, Bryer, Martines,
Dignan (1990) found that subjects who scored positive for substance abuse by the test,
more often than not, did not have the substance-abuse history that the particular scale had
predicted. They explained their findings by calling attention to the fact that the MCMI
Alcohol Abuse scale had only 7 out of 31 questions with specific alcohol abuse content
and the Drug Abuse scale had 5 out of 46 items with drug content.
In a study with opiate-addicts, Marsh, Stile, Stoughton, and Trout-Landen (1988)
found that only 49% of clinical cases in their sample had significant elevations on the
Drug Abuse scale. With college students, Jaffe and Archer (1987) found that MCMI
Alcohol Abuse scale was more effective in detecting drug abuse than was the Drug
Abuse scale. They explained their findings by pointing out a large intercorrelation
between the two scales (r = .65), a very different number than the one originally reported
by Millon (r = -.08; Millon, 1983).
Wetzler (1990) wrote an article reviewing all major studies with the first MCMI
and offered a possible explanation for the poor diagnostic efficiency that was implied by
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these studies. He noted that studies that used structured-interview based criterion
diagnoses generally found adequate diagnostic efficiency for the MCMI, while those that
used diagnoses given by psychiatrists during their standard clinical evaluations found
poor diagnostic efficiency. His conclusion was that, despite its shortcomings, the MCMI
was probably a better diagnostician that the average clinician.
With regards to the instrument’s operating characteristics, the first MCMI manual
reported only sensitivity and specificity values (Millon, 1977). The full set of operating
characteristics of the scales were later calculated and reported by Gilbertini,
Brandenburg, and Retzlaff (1996). The overall diagnostic power (DxP), specificities
(Spec) and negative predictive powers (NPP) were found to be generally high; while
sensitivities (Sens) and positive predictive powers (PPP) varied greatly (sensitivities
ranged from 15% to 91% and PPPs from 19% to 84%). See Tables 3 and 4 for values
concerning the alcohol Abuse and Drug Abuse scales.
Table 3
Operating Characteristics of the MCMI Substance Abuse Scales (BR > 74)
Scale
Alcohol Abuse
Drug Abuse

Prevalence Sensitivity Specificity
17
11

74
78

91
96

PPP

NPP

DxP

63
71

95
97

88
94

Table 4
Operating Characteristics of the MCMI Substance Abuse Scales (BR > 84)
Scale
Alcohol Abuse
Drug Abuse

Prevalence Sensitivity Specificity
12
6

56
52

96
98

PPP

NPP

DxP

66
63

94
97

91
95
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Diagnostic Validity of the MCMI-II
Released in 1987, the MCMI-II retained most of the items that were part of the
original MCMI scales, although both substance abuse scales contained new items.
Similarly to the MCMI, the MCMI-II substance abuse scales had few items with obvious
drug and alcohol content (Bryer et al., 1990). The two scales had 25 items in common
and were reported to have an intercorrelation of .76 (Millon, 1987). Millon’s response to
those who criticize the MCMI for its high scale intercorrelations has always been one;
that the scales overlap is consistent with his theory and that it was intentionally built into
the test to account for the complex nature of the constructs being measured (Millon &
Millon, 1997; Wetzler, 1990). For example, the two substance dependence scales are
expected to measure different but similar constructs, since individuals with alcohol and
drug problems are likely to have tried to overcome their substance abuse problem with
minimal success and experience difficulties in the family and work setting as a result of
the addiction.
Despite the MCMI and MCMI-II recognized overall diagnostic validity
(Gibertini, 1993), Fals-Stewart (1995) alerted clinicians to the effect of defensive
responding (i.e., fake-good) on the instrument’s substance abuse scales. He compared the
scores of substance abuse patients who were asked to respond honestly with those asked
to respond defensively and also with forensic subjects suspected of abusing psychoactive
substances. The results indicated that, even though most MCMI-II items comprising the
substance abuse scales do not directly concern alcohol and drug use, most people
motivated to deny substance abuse can avoid detection. He concluded then that, in
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situations when individuals may feel compelled to hide substance abuse symptoms,
validity of the MCMI-II substance abuse scales may be threatened.
Three studies provided initial support for the validity of the MCMI-II at the time
of its release. These studies examined the extent to which scale scores corresponded to
diagnoses made by clinicians in accordance with the revised 3rd edition of the Diagnostic
and Statistical Manual of Mental Disorders (DSM-III-R; American Psychiatric
Association, 1987) criteria. Based on the results of these studies, Millon reported that
both the Alcohol Dependence and Drug Dependence scales corresponded extremely well
with a diagnosis of alcohol dependence and drug dependence. Their overall diagnostic
power was estimated to be 97% and 94%, respectively (Millon, 1997). Patients diagnosed
with alcohol dependence were reported to also show elevations on Antisocial and
Aggressive scales in Study 1 (N = 20) and on Schizoid and Drug Dependence scales in
studies 2 and 3 combined (N = 43). Patients diagnosed with drug dependence also scored
high on the Alcohol Dependence and Antisocial scales (N = 25 in study 1; N = 53 in
study 2 and 3 combined). A full set of operating characteristics for all scales was reported
in the MCMI-II manual, showing higher positive predictive powers (ranging from .30s to
.80s) than those found with the MCMI (Millon, 1987; cited in Retzlaff, 1996).
Diagnostic Validity of the MCMI-III
Even though Millon claims that the studies conducted with the three generations
of the MCMI can offer support for the validity of its last version (Millon, 1997), there is
disagreement with regards to what extent the MCMI-III is comparable to the MCMI-II.
Some researchers believe that the MCMI-III is sufficiently different and should be
considered a separate instrument (Marlowe, Festinger, & Kirby, 1998; Rogers, Salekin, &
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Sewell, 1999). In fact, in the case of the substance abuse scales, significant changes were
made in the number of items. The Alcohol Dependence scale contained 31 items in the
original MCMI, 46 in the MCMI-II, and only 15 on the MCMI-III. The Drug
Dependence scale consisted of 46 items in the MCMI, 58 in the MCMI-II, and only 16 on
the MCMI-III.
The validity studies reported in the MCMI-III manual used a similar procedure to
the one used with the MCMI-II; patients’ scale scores were compared with diagnoses
made by clinicians on the basis of the 4th edition of the Diagnostic and Statistical Manual
of Mental Disorders (DSM-IV; American Psychiatric Association, 1994) criteria (Millon,
1994; cited in Millon 1997). Only prevalences, sensitivities, specificities and test
positives were initially made available by the test developers. However, using the data
provided in the test manual, Retzlaff (1996) ran a more complete analysis of the
operating characteristics of the MCMI-III and found overall lower PPPs than those
obtained for the MCMI-II, raising a concern that the instrument had lost its diagnostic
properties. See Table 5.

Table 5
The 1994 Study: Prevalence, Sensitivity, Specificity, and Predictive Power Values for
the MCMI-III Substance Abuse Scalesa
Scale
Alcohol Abuse
Drug Abuse
a

Retzlaff (1996).

Prevalence

Sensitivity

Specificity

PPP

NPP

12.40
8.20

72.70
51.70

85.80
94.80

42
47

96
96
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Considering that the MCMI-III remained very similar to the MCMI-II in terms of
its overall scale composition and reliability, Retzlaff (1996) argued that the poor results
were more likely due to a faulty validity study than to a poorer test. He pointed out
several methodological problems in the 1994 study, including limitations of the
diagnostic criteria employed (e.g., clinicians were asked to make diagnoses based on the
new DSM-IV criteria, which was unavailable at the time), the superficial level and low
frequency of contact between clinical judges and patients (e.g., clinicians diagnosed cases
with as low as one clinical contact), and the diversity in purposes of the study (the
validity study was mixed-in with the item-selection study), among other problems.
In response to Retzlaff’s article, MCMI developers carried out a new validity
study with the MCMI-III in an attempt to replicate the conditions under which the
MCMI-II study was conducted (e.g., in the new study, raters had to have seen the patients
for at least three therapeutic sessions and had to have a good understanding of the
patient’s clinical features and personality characteristics before making a diagnosis). The
revised MCMI-III manual (Millon, 1997) described the methodology used in this study
and provided a comparative table of diagnostic efficiency statistics across the three
generations of the MCMI (see Tables 6 and 7 for the Alcohol Dependence and Drug
Dependence scales statistics). According to the test developers, specificities and NPPs
were not reported due to the fact that these statistics tend to be grossly inflated for the
MCMI because of the number of scales included in the calculations (Millon, 1997; Davis,
Wenger, & Guzman, 1997). Nevertheless, Retzlaff (2000) calculated NPPs with the new
data and found that they were all equal or greater than .94. Overall, values for the
diagnostic validity statistics for the second study were found to be much higher than
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those derived from the first, suggesting that the 1994 study underestimated the diagnostic
value of the MCMI-III (Millon, 1997; Retzlaff, 2000).

Table 6
The 1997 Study: Comparative Table of the Operating Characteristics of the Three
Generations of the MCMI Substance Abuse Scales at BR equal or higher than 75a
Prevalence Rates

a

Sensitivity

Positive Predictive
Power

M-I

M-II

M-IIIb

M-I

M-II

M-IIIb

M-I

M-II

M-IIIb

Alcohol
Abuse

17

15

30

74

87

86

63

92

83

Drug
Abuse

11

13

19

78

72

92

71

82

89

MCMI-III values were calculated from data obtained in the 1997 study (Millon, 1997).
Statistic calculated using all disorders judged by clinicians as present.

b

Table 7
The 1997 Study: Comparative Table of the Operating Characteristics of the Three
Generations of the MCMI Substance Abuse Scales at BR equal or higher than 85 a
Prevalence Rates

Sensitivity

Positive Predictive
Power

M-I

M-II

MIIIb

MIIIc

M-I

M-II

MIIIb

MIIIc

M-I

M-II

MIIIb

MIIIc

Alcohol
Dependence

12

8

30

17

56

79

65

80

66

88

91

88

Drug
Dependence

6

9

19

11

52

62

78

82

63

78

92

93

a

MCMI-III values were calculated from data obtained in the 1997 study (Millon, 1997).
Statistic calculated using all disorders judged by clinicians as present.
c
Statistic calculated using disorders judged by clinicians as most prominent.
b

After reviewing the methodology and results of these two MCMI-III validity
studies, Hsu (2002) concluded that the 1994 study, despite its limitations, provided a
better appraisal of the validity of the MCMI-III. He argued that even though the 1997
study overcame the major limitation of the 1994 study (lack of familiarity of clinicians
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with patients), it did not provide adequate control for “criterion contamination,
confirmatory bias, or availability heuristics;” thus, providing an overestimation of the
validity of the MCMI-III. According to Hsu (2002), a major methodological flaw of the
1997 study is that, in order to obtain a large clinical sample, clinicians were encouraged
to include subjects who had already taken the MCMI-III. Although they were asked not
to include those patients for whom they had a clear recollection of MCMI-III scores, it is
hard to believe that prior knowledge of patients profiles did not influence their clinical
judgment; “after all, it is precisely this type of information that clinicians would be
expected to pay attention to and remember, especially if they believed that the MCMI-III
scale elevations yielded useful clinical information” (p. 420). In addition, clinicians were
provided with a single rating form to enter both their clinical ratings of the patients’
symptoms and traits and the subjects’ MCMI-III scores. Thus, even if clinicians had no
clear recollection of the patients’ scores at the time of the study, having to enter these
scores on the same form they recorded diagnoses may have biased their clinical
judgment.
In the same article, Hsu (2002) also discussed the importance of diagnostic
validity indices used less frequently in the MCMI literature that make adjustments for
chance agreement of scale scores and for inability of a scale to discriminate between
groups (IPPP, INPP, Cohen’s Kappa, Cohen’s Effect Size, and AUC). He demonstrated
that, if consideration had been given to these indices, different conclusions about the
1994 study would have been reached. In spite of the importance researchers traditionally
place on PPPs, Hsu (2002) argued that low PPPs do not imply worse-than-chance
diagnoses. In fact, based on the 1994 data, he found that 20 out of the 24 MCMI-III
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scales performed better-than-chance. With regards to the substance abuse scales, IPPP
and INPP values were .296 and .084 for Alcohol Dependence; and .388 and .042 for
Drug Dependence, respectively. Cohen’s Kappa for the Alcohol Dependence scale was
.454, and .465 for the Drug Dependence scale. Effect sizes were above 1.5 for both
scales. Diagnostic validity values based on the 1997 study were much higher than values
based on the 1994 study but should be interpreted with caution due to possible
overestimation. See Table 8 for values reported by Hsu (2002).

Table 8
Comparative Table of the 1994 and 1997 Additional Diagnostic Validity Values for the
MCMI-III Alcohol and Drug Dependence Scalesa
PPP

a

IPPP

INPP

Cohen’s k

Cohen’s d

AUC

1994

1997

1994

1997

1994

1997

1994

1997

1994

1997

1994

1997

Alcohol
Dependence

.420

.88

.296

.71

.084

.13

.454

.81

1.68

2.85

.882

.98

Drug
Dependence

.470

.93

.388

.82

.042

.09

.465

.86

1.67

3.34

.881

.99

Hsu (2002).

Although several independent studies provided additional information on the
validity of the original MCMI substance abuse scales, only one independent study with
substance abusers was conducted with the MCMI-III (Craig, 1997). This study reported
sensitivity and specificity rates for the Alcohol Dependence and Drug Dependence scales
with a sample of 164 substance misusers from an inpatient drug treatment and
rehabilitation program. All subjects met diagnostic criteria for opiate or cocaine
dependence and 80 percent of the sample had a concurrent diagnosis of alcohol abuse or
alcohol dependence. The results showed an overall sensitivity level of .80 for the Alcohol
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Dependence scale and .82 for the Drug Dependence scale. Because prevalence of drug
use was 100 percent, no specificity and NPP values for the Drug Dependence scale were
obtained with this sample. Specificity for the Alcohol Dependence scale was .59 and NPP
was .62. PPP values were 1.0 for Drug Dependence and .84 for Alcohol Dependence.
Because all subjects in this sample were in treatment for substance abuse (prevalence was
100 percent for drug abuse and 80 percent for alcohol abuse), the high PPP values
obtained for both substance abuse scales are not surprising.
Concluding Remarks
The Millon Clinical Multiaxial Inventory is considered to be one of the major
personality inventories in the United States, having spawned more than 600 papers since
its first publication in 1977. Overall, the instrument is considered to be a well-designed
and psychometrically stable inventory, distinguishing itself from a number of comparable
tests currently available in the market (Aiken, 1997; Groth-Marnat, 2003). The
instrument’s success among clinicians and researchers is due to its several distinguishing
features, including relative brevity (when compared with similar personality inventories
such as the Minnesota Multiphasic Personality Inventory - MMPI), strong theoretical
basis, simplicity of administration and scoring, multiaxial format, and consonance with
the DSM-IV (Choca & Van Denburg, 1997; Craig, 1997, Millon, 1997).
With regards to its usefulness for detecting substance abuse problems, the MCMI is
unique in that it provides the opportunity for assessing addictive behaviors in the context of
personality styles and psychopathology. Millon’s theory predicts that clinical syndromes,
such as substance abuse or dependence, tend to emerge under periods of greater stress and
are often reflective of disturbances in underlying personality patterns. A discussion of
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personality clusters associated with substance abuse is beyond the scope of this proposed
study. For a review of the literature on this topic, please refer to Choca and Van Denburg,
1997; and Flynn and McMahon, 1997.
Cross-Cultural Applications of the MCMI
The Challenges of Cross-Cultural Assessment
The field of cross-cultural psychology has grown considerably over the last
several decades, raising awareness among clinicians and researchers of the need for the
development of culturally-sensitive assessment practices (Aponte & Crouch, 2000; Dana,
2000). Recognition of the impact of sociocultural factors in intelligence, personality,
psychopathology and other constructs of interest to psychologists has led to efforts to
develop psychological instruments guided by one of two underlying approaches: (a) one
that seeks to create universal definitions of normality and abnormality, and to develop
instruments that measure those universal constructs (etic perspective); or (b) another that
regards culture as an inseparable factor in the development of individuals’ characteristics,
and argues in favor of creating instruments that are culture-specific (emic perspective)
(Dana, 1988; see Helfrich, 1999, for a more complete discussion on the etic-emic
controversy).
Undoubtedly, both methods have limitations and can not easily resolve the
challenges of multicultural and cross-cultural assessment. While the emic approach
seems ideal in that it emphasizes the need for understanding individuals in their social
context, it also implies the need for the development of an inordinate number of
instruments for a given construct, one from within each existing culture. Aside from the
enormous expense involved in the development of multiple tests, a major limitation of

31
this method is the fact that it makes it impossible for researchers and clinicians to
compare an individual’s or cultural group’s performance cross-culturally (Samuda,
1998). On the other hand, the etic approach also poses its own set of problems for
assuming the existence of universal truths, which some argue may be too difficult to find
or even impossible to separate from the always-present influence of culture in human
behavior (van de Vijver & Poortinga, 1991; cited in Dana, 1988).
MCMI Translations
Despite the trend for developing culture-specific instruments (Dana, 1987; Dana,
2000) and many methodological problems involved in the development of high quality
test translations (Bracken & Barona, 1991; Butcher, 1996a; Geisinger, 1994; van de
Vijver & Poortinga, 1991; van de Vijver & Hambleton, 1996), translations of
psychological measures continue to be widely used and offer a less-than-ideal but
functional solution to the challenges of multicultural assessment in the context of both
cross-cultural research and culturally-sensitive clinical practice. Because the translation
process of an instrument is a costly and time-consuming task, the literature advises that
care should be exercised in selecting for translation only tests that are theoretically sound,
psychometrically reliable, and demonstrate adequate validity in the original language.
The MCMI clearly meets these criteria. In addition to being generally recognized
as a reliable and valid instrument, the MCMI has a strong theoretical foundation. In his
evolutionary and ecological theory of personality, Millon proposed that human behavior
is directed by three “motivating aims,” which he defined as the bipolar dimensions of
pleasure-pain, active-passive, and self-other (Millon, 1990; Millon, 1994; cited in
Escovar, 1997). According to Millon, individual organisms are born with the potential for
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developing certain traits based on their genetic makeup, but “over time the salience of
these trait potentials become differentially prominent as the organism interacts with its
environment” (Millon, 1990, p. 22). Although a full discussion of Millon’s theory is
beyond the scope of this study, it is important to note that his model for understanding
human behavior parallels similar models used to explain differences between cultural
groups and has been recognized as having the potential for helping to elucidate crosscultural questions (Escovar, 1997).
The literature indicates that several MCMI translations have been developed and
are currently being used in many other countries (Groth-Marnat, 2003); however, with
the exception of a translation into Dutch-Flemish developed for use in the Netherlands
and Belgium (Luteijn, 1990; Mortensen & Simonsen, 1990; Sloore & Derksen, 1997), no
other information was found regarding international applications of the MCMI.
With regards to the Dutch-Flemish MCMI validity for diagnosing substance
abuse, a study comparing patients’ scores on the translated MCMI and translated MMPI
(N=52) found a correlation of .51 for the MCMI Alcohol Abuse scale and the MMPI
McAndrew scale. A correlation of .58 was found for the MCMI Drug Abuse scale and
the MMPI McAndrew scale (Sloore & Derksen, 1997).
Purpose of the Study
The purpose of this study was to provide a preliminary appraisal of the usefulness of
the Brazilian-Portuguese version of the MCMI-III (BP-MCMI-III) for cross-cultural
applications. More specifically, this study examined the validity of the BP-MCMI-III
Alcohol

Dependence

and

Drug

Dependence

scales

for

detecting

substance

abuse/dependence problems in a Brazilian sample composed of clinical and non-clinical
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subjects. The focus was on evaluating the diagnostic validity of these scales by comparing
participants’ group status (patients receiving substance abuse treatment versus controls)
against diagnoses made on the basis of the test (Hypothesis 1 and Hypothesis 2), and by
comparing diagnoses made on the basis of the DSM-IV-TR against diagnoses made on the
basis of the test (Hypothesis 3 and 4). In addition, the construct validity of the Alcohol
Dependence scale was examined by comparing the subjects’ scores on the BP-MCMI-III
against scores on the AUDIT (Hypothesis 5). Because this investigator did not find a
concurrent measure of drug abuse/dependence in Portuguese that could be used in this
study, the concurrent validity of the Drug Dependence scale was not tested.
Hypothesis 1
It was expected that clinical subjects would have a significantly higher raw and base
rate score than controls on the Alcohol Dependence scale of the Brazilian-Portuguese
version of the Millon Clinical Multiaxial Inventory-III (BP-MCMI-III), when clinical and
control groups were defined based on whether individuals were receiving or not receiving
treatment for alcohol-related problems at the time of testing.
Hypothesis 2
It was expected that clinical subjects would have a significantly higher raw and base
rate score than controls on the Drug Dependence scale of the Brazilian-Portuguese version
of the Millon Clinical Multiaxial Inventory-III (BP-MCMI-III), when clinical and control
groups were defined based on whether individuals were receiving or not receiving treatment
for drug-related problems at the time of testing.
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Hypothesis 3
It was expected that individuals diagnosed with alcohol abuse or dependence based
on DSM-IV-TR criteria would have a significantly higher raw and base rate score than
controls on the Alcohol Dependence scale of the Brazilian-Portuguese version of the Millon
Clinical Multiaxial Inventory-III (BP-MCMI-III).
Hypothesis 4
It was expected that individuals diagnosed with drug abuse or dependence based on
DSM-IV-TR criteria would have a significantly higher raw and base rate score than controls
on the Drug Dependence scale of the Brazilian-Portuguese version of the Millon Clinical
Multiaxial Inventory-III (BP-MCMI-III).
Hypothesis 5
It was expected that there would be a significant positive correlation between
participants’ scores on the Alcohol Dependence scale of the Brazilian-Portuguese version of
the Millon Clinical Multiaxial Inventory-III (BP-MCMI-III) and scores on the Alcohol Use
Disorders Identification Test (AUDIT).
Post Hoc Analyses
The following questions regarding indices of diagnostic validity were answered:
(1) What is the sensitivity of the BP-MCMI-III Alcohol and Drug Dependence
scales?
(2) What is the specificity of the BP-MCMI-III Alcohol and Drug Dependence
scales?
(3) What is the Positive Predictive Power (PPP) of the BP-MCMI-III Alcohol and
Drug Dependence scales?
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(4) What is the Negative Predictive Power (NPP) of the BP-MCMI-III Alcohol
and Drug Dependence scales?
(5) What is the Overall Diagnostic Power (DxP) of the BP-MCMI-III Alcohol and
Drug Dependence scales?
(6) What is the Incremental Validity of Positive Test Diagnoses (IPPP) of the BPMCMI-III Alcohol and Drug Dependence scales?
(7) What is the Incremental Validity of Negative Test Diagnoses (NPPP) of the
BP-MCMI-III Alcohol and Drug Dependence scales?
(8) What is the value of Cohen’s Kappa for the BP-MCMI-III Alcohol and Drug
Dependence scales?
(9) What is Cohen’s Effect Size for the BP-MCMI-III Alcohol and Drug
Dependence scales?
(10) What is the Area Under the ROC curve for the BP-MCMI-III Alcohol and
Drug Dependence scales?
Furthermore, diagnostic validity indices for the Brazilian version of the AUDIT
used in this study were computed as they have not yet been reported in the literature.
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CHAPTER III
Method
Participants
Clinical Participants
Clinical participants were contacted through two substance abuse treatment
facilities in Rio de Janeiro, Brazil – Clínica Pater-Aldeia and Primeira Clínica Popular do
Estado do Rio de Janeiro (see the Procedures section for details about how subjects were
recruited). They were invited to participate in this study by responding anonymously to
the assessment materials. All potential participants were fully informed about the purpose
of the investigation, the procedures involved, the risks and benefits associated with their
participation, and their right to withdraw from the study at any time. They were assured
that their answers would be kept confidential and those who agreed to participate were
asked to sign an Informed Consent Form (See Appendixes C and D). The criteria for
inclusion were: (1) subject’s willingness to participate; (2) being above eighteen years of
age; and (3) being in inpatient or outpatient treatment for alcohol/drug abuse or
dependence at the time of testing.
A total of 75 patients receiving substance abuse treatment responded to the
assessment materials. Twenty-three patients were receiving treatment due to alcohol
related disorders only, 12 due to drug related disorders only, and 40 had diagnoses of
both alcohol and drug related problems. Clinical participants were mostly male, single,
unemployed, and Catholic. Approximately 63% had completed a minimum of 8th grade
level education. Patients’ age ranged from 18 to 60 (M = 37; SD = 10).
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Non-Clinical Participants
Non-clinical participants were contacted through two churches in Rio de Janeiro,
Brazil – the Igreja Prebiteriana Betânia and the Igreja Congregacional de Vila Paraíso
(see the Procedures section for details about how participants were recruited). They were
fully informed about the purpose of the investigation, the procedures involved, the risks
and benefits associated with their participation, and their right to withdraw from the study
at any time. They were assured that their answers would be kept confidential and those
who agreed to participate voluntarily were asked to sign an Informed Consent Form. The
criteria for inclusion were: (1) subject’s willingness to participate; (2) being above
eighteen years of age; (3) receiving no treatment for substance abuse at the time of
testing; and (4) having no history of substance abuse treatment. The decision to recruit
non-clinical participants through churches was based on this investigator’s relative easy
access to this population through local contacts.
The non-clinical sample was composed of 33 female and 18 male participants
(N=51), with ages ranging from 19 to 67 years (M = 34; SD = 13). Most non-clinical
participants identified themselves as members of the protestant church, were either single
or married, and had completed a minimum of 8th grade education. Approximately 50%
had either college or graduate degrees. With regards to occupation, only 6% were
unemployed. Table 9 presents a detailed description of the clinical and non-clinical
samples, as well as of sub-samples within the clinical group (patients with alcohol-related
problems only, patients with drug-related problems only, and patients receiving treatment
for both alcohol- and drug-related problems).
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Table 9
Demographic Information

Age*
Mean and (SD)
Range
Gender*
Male
Female
Marital Status**
Single
Married
Widowed
Separated/Divorced
Occupation*
Office
Factory
Professional
Unemployed
Other
Education*
Elementary Incomplete
Elementary Complete
Middle Incomplete
Middle Complete
High Incomplete
High Complete
College Incomplete
College Complete
Graduate Incomplete
Graduate Complete
Religion*
None
Protestantism
Catholicism
Spiritism
Afro-Brazilian
Other
Alcohol Treatment Hx*
Never
1 – 2 times
3 – 4 times
> 4 times
Drug Treatment Hx***
Never
1 – 2 times
3 – 4 times
> 4 times
Frequency of Drinking**
Never
1 time per month or less
2 – 4 times per month
2 – 3 times per week
4 or more times per week

Alcohol Only

Drug Only

Alcohol and
Drug

Total Clinical
Sample

Non-Clinical
Sample

N = 23

N = 12

N = 40

N = 75

N = 51

43 (8)
19 – 57

32 (9)
18 – 48

35 (9)
19 – 60

37 (10)
18 – 60

34 (13)
19 – 67

19
4

9
3

31
9

59
16

18
33

11
8
1
3

6
3
0
3

19
9
1
10

36
20
2
16

26
22
0
3

0
3
6
8
6

1
0
1
7
3

5
2
4
16
13

6
5
11
31
22

11
0
14
3
23

2
0
5
3
5
3
4
1
0
0

1
3
3
0
1
2
1
1
0
0

4
1
9
8
3
6
4
2
3
0

7
4
17
11
9
11
9
4
3
0

0
0
1
0
2
11
12
14
2
9

2
3
13
4
0
1

1
1
7
1
1
1

8
7
15
6
3
1

11
11
35
11
4
3

0
48
2
0
0
1

11
9
2
1

8
4
0
0

19
13
1
7

38
26
3
8

51
0
0
0

20
2
0
0

7
3
1
0

16
12
4
7

43
17
5
7

51
0
0
0

0
0
0
4
19

7
0
3
1
0

2
1
1
6
30

9
1
4
11
49

31
12
5
3
0

* N = 126; ** N = 125; *** N = 123
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Control Groups
The composition of clinical and control groups varied for each hypothesis. For
testing hypothesis 1, the clinical group was composed of participants who were receiving
treatment for alcohol-related problems only (N = 23) and those who were receiving
treatment for both alcohol- and drug-related problems (N = 40) at the time of testing. The
control group was composed of non-clinical participants (N = 51).
For hypothesis 2, the clinical group was composed of participants who were
receiving treatment for drug-related problems only (N = 12) and those who were
receiving treatment for both alcohol- and drug-related problems (N = 40) at the time of
testing. The control group was composed of non-clinical participants (N = 51).
For hypothesis 3, the clinical group was composed of participants who were
identified as having either an alcohol abuse or an alcohol dependence diagnosis according
to DSM-IV-TR criteria (N = 66); the control group was composed of participants who did
not meet DSM-IV-TR criteria for alcohol-related disorders (N = 60).
For hypothesis 4, the clinical group was composed of participants who were
identified as having either a drug abuse or a drug dependence diagnosis according to
DSM-IV-TR criteria (N = 72); the control group was composed of participants who did
not meet DSM-IV-TR criteria for drug-related disorders (N = 54).
Statistical Differences Between Clinical and Control Groups
Group equality was tested by performing chi-square tests on the following
variables: gender, marital status, occupation, education, religion, alcohol treatment
history, drug treatment history, and frequency of drinking. A t-test was used for testing
equality in terms of age. The results indicated that the clinical and control groups (a) were
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non-equivalent on all of these variables, except age, for hypothesis 1; (b) were nonequivalent on all variables, except age, for hypothesis 2; (c) were non-equivalent on all
variables, except marital status, for hypothesis 3; and (d) were non-equivalent on all
variables, except age, for hypothesis 4. Tables 10 through 13 present the results of these
tests.

Table 10
Tests of Group Equality on Demographic Variables for Hypothesis 1 (N = 114)
Variable
Age**
Gender
Marital Status*
Occupation
Education
Religion
Alcohol Treatment Hx
Drug Treatment Hx**
Frequency of Drinking

t / x2

Df

P

1.91
22.74
8.18
23.63
49.47
70.28
37.60
26.91
89.96

110
1
3
4
9
5
3
3
4

.059
.000
.042
.000
.000
.000
.000
.000
.000

* N = 113; ** N = 112

Table 11
Tests of Group Equality on Demographic Variables for Hypothesis 2 (N = 103)
Variable
Age**
Gender
Marital Status*
Occupation
Education
Religion
Alcohol Treatment Hx
Drug Treatment Hx**
Frequency of Drinking*
* N = 102; ** N = 101

t / x2

Df

P

.16
18.14
10.21
24.37
46.64
65.57
37.59
44.22
53.12

99
1
3
4
9
5
3
3
4

.874
.000
.017
.000
.000
.000
.000
.000
.000
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Table 12
Tests of Group Equality on Demographic Variables for Hypothesis 3 (N = 126)
Variable
Age**
Gender
Marital Status*
Occupation
Education
Religion
Alcohol Treatment Hx
Drug Treatment Hx***
Frequency of Drinking*

t / x2

Df

P

2.24
21.48
4.77
12.89
33.16
57.71
21.28
14.40
99.94

122
1
3
4
9
5
3
3
4

.027
.000
.190
.012
.000
.000
.000
.002
.000

* N = 125; ** N = 124; ** N = 123

Table 13
Tests of Group Equality on Demographic Variables for Hypothesis 4 (N = 126)
Variable
Age**
Gender
Marital Status*
Occupation
Education
Religion
Alcohol Treatment Hx
Drug Treatment Hx**
Frequency of Drinking*

t / x2

Df

P

.80
11.05
10.96
11.73
27.61
38.16
20.29
40.57
20.92

122
1
3
4
9
5
3
3
4

.423
.001
.012
.019
.001
.000
.000
.000
.000

* N = 125; ** N = 124; ** N = 123

Data Collection Sites
Clínica Pater-Aldeia
The Pater-Aldeia Clinic is a privately owned substance abuse facility located in an
upper-middle-class suburban area near the city of Rio de Janeiro. This clinic has been
operating since 1990 and is staffed with a multidisciplinary clinical team that includes a
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general physician, a psychiatrist, a counselor, a psychologist, an occupational therapist,
and several nurses. The clinic provides residential treatment for up to 15 insured and
private-pay patients with alcohol and/or drug problems. The minimum length of stay is
30 days, with some patients staying up to 45 days. Approximately 13% of the clinical
data (10 subjects) were collected at this site.
Primeira Clínica Popular do Estado do Rio de Janeiro
The Primeira Clínica Popular do Estado do Rio de Janeiro – First Popular Clinic
of the State of Rio de Janeiro - provides inpatient and outpatient substance abuse
treatment free of charge to low-income patients in the suburban city of Santa Cruz. The
clinic is a non-governmental agency funded by the state and has been operating since
2000. It is staffed with a multidisciplinary clinical team that includes several
psychologists, physicians, occupational therapists, family therapists, social workers,
nurses and health technicians. The clinic provides inpatient treatment for up to 90 patients
with alcohol and/or drug problems. The typical length of stay is 40 to 45 days. After
discharge, patients continue treatment on an outpatient basis for up to 9 months.
Approximately 87% of the clinical data (65 subjects) were collected at this site. All
participants were inpatients.
Igreja Congregacional em Vila Paraíso
With approximately 250 members, the Congregational Church of Vila Paraíso is a
Protestant church located in a lower-middle-class suburban area near the city of Rio de
Janeiro. Approximately 57% of the non-clinical data (29 participants) were collected at
this site.
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Igreja Presbiteriana Betânia
Located in an upper-middle-class suburban area near the city of Rio de Janeiro,
the Presbyterian Church Betânia is a Protestant church with approximately 400 members.
Approximately 43% of the non-clinical data (22 participants) were collected at this site.
Table 14 presents frequency and percentages of clinical and non-clinical participants by
site.

Table 14
Frequency and Percentages of Clinical and Non-Clinical Participants by Site
Sites

Frequency

% within Group

% Total

10
65
75

13.3
86.7
100.0

7.9
51.6
59.5

29
22
51

56.9
43.1
100.0

23.0
17.5
40.5

Clinical
Pater-Aldeia Clinic
Popular Clinic of Rio de Janeiro
Clinical Total
Non-Clinical
Congregational Church
Presbyterian Church
Non-Clinical Total

Instrumentation
BP- MCMI-III Alcohol Dependence and Drug Dependence Scales
The Brazilian-Portuguese MCMI-III is a paper and pencil inventory containing
175 true-false items. Like the original MCMI-III, the BP-MCMI-III has a total of 27
subscales: (a) three for estimating the individual’s test-taking attitude, (b) 14 for
measuring different personality styles, and (c) 10 for assessing the presence of clinical
syndromes, including anxiety, depression, psychotic disorders, posttraumatic stress, and
substance-related problems (Millon, 1997).
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The MCMI-III was translated by this investigator and other members of the
research team using a combination of translation practices discussed in the literature,
which included the use of a translation committee, the use of translation revisers, a
backtranslation procedure, a bilingual test-retest pilot, and a final revision of the problemitems (Bracken & Barona, 1991; Geisinger, 1994; Butcher, 1996a; Butcher, 1996b; Butcher
& Hans, 1996; Sperber, Devellis, & Boehlecke, 1994; Van de Vijver, F., & Hambleton,
R. K., 1996). All 15 items that comprised the original Alcohol Dependence scale and all
14 items that comprised the original Drug Dependence scale remained in the translated
version. No changes were made in the structure of the scales or in the content of the
items. See Appendices E and F for more details on the scales’ composition and item
weighing for the original and translated versions.
High scores on the Alcohol Dependence scale are expected to be indicative of
current problematic drinking or a history of alcoholism with associated symptoms such as
subjective distress, family problems, and deficits in social and occupational functioning.
Similarly, high scores on the Drug Dependence scale are expected to be indicative of
current drug use or a history of drug addiction with associated symptoms (Craig, 1993).
A reliability study with 220 Brazilian college students in Rio de Janeiro found test-retest
coefficients of .70 and .85 for the BP-MCMI-III Alcohol Dependence and Drug
Dependence scales, respectively (Magalhaes et al., 2004). Please refer to Appendices A
and B for a detailed description of the methodological procedures used for the translation
of the MCMI-III into Brazilian-Portuguese and the results of preliminary studies.
Due to the fact that the Portuguese language has gender-specific words, the
development of gender-specific forms was deemed appropriate for use in the present study.
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The BP-MCMI-III used in prior studies contained words in the masculine form only. The
gender-specific forms that were used in this study were equal in content, but were expected
to facilitate the readability of the items. The following are examples of items that were
modified (gender-specific words are shown in bold).

Item 18:
a) Tenho receio de me aproximar de outra pessoa porque
posso acabar sendo ridicularizado ou humilhado
(masculine form).
b) Tenho receio de me aproximar de outra pessoa porque
posso acabar sendo ridicularizada ou humilhada
(feminine form).
Item 90:
c) Às vezes fico confuso e me sinto perturbado quando as
pessoas são gentis comigo (masculine form).
d) Às vezes fico confusa e me sinto perturbada quando as
pessoas são gentis comigo (feminine form).

Diagnostic Questionnaire
A diagnostic questionnaire was used to determine the presence or absence of
substance abuse disorders according to the DSM-IV-TR criteria. This questionnaire is a
self-report symptom checklist that contains 11 yes-no questions about substance use
patterns, each corresponding to a specific diagnostic criterion listed under the DSM-IV-
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TR diagnostic code. Separate forms for alcohol and drug abuse/dependence were
available.
Structured diagnostic interviews are commonly used in substance abuse research
and are generally considered reliable instruments for use with both clinical samples and
the general population (Grant and Towle, 1990; Grant, 1997). The diagnostic instrument
that was used in this study is a reduced version of the Alcohol Use Disorder and
Associated Disabilities Interview Schedule (AUDADIS), one of the most widely used
diagnostic instruments of this type. The AUDADIS operationalized the DSM-IV criteria
for alcohol abuse and dependence and relies exclusively on respondent self-report (Grant,
1992). A study with the AUDADIS found the combined diagnoses of lifetime alcohol
abuse and dependence to be highly reliable (Grant, Harford, Dawson, Chou, and
Pickering, 1995).
The translation of this instrument into Brazilian-Portuguese was completed by this
investigator, with the assistance of a professional translator. The translated version was
then backtranslated into English by a bilingual research assistant (Brazilian native) and
compared with the original version by a monolingual English speaker (American native).
No major discrepancies were found between the two English versions and only minimal
changes were made on the final Brazilian-Portuguese version that was used in this study.
Diagnoses made on the basis of this questionnaire were compared against diagnoses
made on the basis of the BP-MCMI-III to test this study’s primary hypotheses (3 and 4)
and to calculate diagnostic efficiency indices for both substance dependence scales of the
BP-MCMI-III. Appendices G and H present the English and Portuguese versions.
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Brazilian-Portuguese Version of the Alcohol Use Disorders Identification Test
The Alcohol Use Disorders Identification Test (AUDIT) was developed by the
World Health Organization (WHO) in a six-country collaborative project for early
detection of problem drinking, as part of a brief intervention trial (Saunders & Aasland,
1987). The instrument has been recognized as a highly sensitive measure that has the
advantage of detecting hazardous drinking separate from alcohol dependence, a feature
that is considered an improvement over other screening questionnaires that were
available at the time of its development. Unlike the MCMI-III Alcohol Dependence scale,
which assesses drinking problems in the context of general psychopathology, the AUDIT
was developed specifically for the detection of problem drinking in primary care settings,
where hazardous drinkers seek medical treatment for other health-related concerns
(Saunders, Aasland, Babor, De La Fuente, & Grant, 1993; Miles, Winstock, & Strang,
2001; Maisto, S. A., Conigliaro, J., McNeil, M., Kraemer, K., & Kelley, M. E., 2000;
Allen, Litten, Fertig, & Babor, 1997; Fleming, Barry, & MacDonald, 1991). Another
important and unique feature of the AUDIT is the fact that its developers were careful to
select items that were conceptually and empirically valid cross-culturally. Items were
derived from a large cross-national data set (N = 1888) and checks were made to ensure
that none performed poorly in any individual national sample. Participating nations were
Australia, Bulgaria, Kenya, Mexico, Norway and the United States (Saunders, Aasland,
Babor, De La Fuente, & Grant, 1993).
The AUDIT is a paper and pencil “yes-no” questionnaire composed of 10 items
related to alcohol consumption patterns – three questions on the amount and frequency of
drinking, three questions on harmful use of alcohol, and four on alcohol-related
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consequences – and scores ranging from 0 to 40. Different cut-off scores have been
suggested in the literature. The original 1987 study conducted by the WHO
recommended a score of 11 or more as indicative of a drinking problem (Babor, T.,
Korner, P., & Wilber, C., 1987; cited in Fleming, Barry, & MacDonald, 1991), but other
studies have used a cut-off score of 8 (Reinert & Allen, 2002; Conigrave, Hall, &
Saunders, 1995; Maisto, S. A., Conigliaro, J., McNeil, M., Kraemer, K., & Kelley, M. E.,
2000).
In a review of the AUDIT literature (English language version), Reinert and Allen
(2002) reported that the instrument has proven to be internally consistent with diverse
samples and in different settings, with median Chronbach’s alpha falling in the .80s for
the 18 studies included in the review. The four studies that tested the temporal reliability
of the English AUDIT over a two-week interval found results ranging from .64 to .92.
The median sensitivity was .86 and the median specificity was .89 for a cut-off score of
8, across 13 studies.
When researching for a Brazilian-Portuguese translation of the AUDIT to be used
in this study, three were found. The first, by Figlie’s research team, was used in a
published study that looked at the frequency of smoking and problem drinking among
general hospital inpatients in Sao Paulo, Brazil (Figlie, Pillon, Dunn & Laranjeira, 2000).
In personal correspondence with the author (Figlie, 2004), Figlie reported that the
reliability and validity of her translation was not tested, but graciously provided copy of
an unpublished Masters thesis on a different translation of the AUDIT, developed by one
of her colleagues (Méndez, 1999). Méndez developed a more systematic translation and
tested its validity against diagnoses of alcohol abuse made on the basis of the ICD-10
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criteria. His total sample was composed of 733 participants (486 had at least one drink in
the past 12 months) recruited through two primary care facilities – a hospital and an
outpatient clinic that serve low-income communities in the outskirts of Pelotas, southern
Brazil. For a cut-off score of 8, sensitivity was .92 and specificity was .62. In order to
improve specificity while keeping sensitivity within an acceptable level, Méndez
suggested the use of a cut-off score of 10 (sensitivity = .88; specificity = .80). Table 15
shows validity indices for cut-off scores of 8, 10, 11, 12, 14 and 16.

Table 15
Validity Indices of the Brazilian-Portuguese AUDIT for Diagnosing Alcohol Abusea

Sensitivity
Specificity
Accuracy
Positive Predictive Power
Negative Predictive Power
Classification Error
a

8

10

Cut-off Scores
11
12

.92
.62
.68
.35
.97
.32

.88
.80
.82
.49
.97
.18

.84
.84
.84
.53
.96
.16

.84
.86
.86
.57
.96
.14

14

16

.74
.92
.88
.66
.94
.12

.65
.94
.89
.71
.93
.11

Méndez (1999)

More recently, a revision of Méndez’s translation was developed by Erikson
Furtado’s research team in São Paulo, Brazil, in collaboration with the WHO and
researchers associated with the University of Connecticut. The Connecticut group is
working under the leadership of Thomas Babor, one of the principal investigators
involved in the development of the original AUDIT. In personal correspondence with
Furtado (May 3, 2004), he reported that his new Portuguese version was developed with
the objective of incorporating the most current changes made on the international version
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of the AUDIT. His research group also produced a translation and adaptation of the
AUDIT manual and the Brief Interventions manual released by the WHO in 2001 (Babor,
Higgins-Biddle, Saunders & Monteiro, 2001; Babor & Higgins-Biddle, 2001).
When comparing the two versions, Furtado’s differs from Méndez’s in two ways:
(1) less formal use of the Portuguese language; and (2) modifications in the number of
standard-drinks for the question in item number 2 and the answer options in item number
3, to accommodate for differences in the amount of alcohol contained in typical Brazilian
drinks (Furtado, 2004). Furtado reported that his team has not yet tested the reliability
and validity of his revised Portuguese AUDIT but does not anticipate that he will find
major differences from results obtained with Méndez’s version. Although it is likely that
the revised instrument remains valid, it is possible however that the changes made in the
number of standard-drinks for items 2 and 3 will affect the operational characteristics of
the instrument and, consequently, the selection of appropriate cut-off scores.
Despite the lack of new validity data to support the revised translation, five
factors influenced this investigator’s decision to use Furtado’s version in this study: (1) it
was developed in collaboration with the original developers of the test, (2) it is up-to-date
with the most current AUDIT manual, (3) the wording of the questions is more casual
and more appropriate for the location where the data will be collected, (4) items were
adapted to account for differences in the amount of alcohol contained in typical Brazilian
drinks, and (5) cut-off scores will not be needed for analysis (total scores will be used).
See Appendix I for the AUDIT in English and Appendix J for the Portuguese version that
was used in this study.
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Demographic Questionnaire
The demographic questionnaire gathered information about the subjects’ age,
gender, marital status, education, religion, occupation, history of substance abuse
treatment, and reason for current admission to a substance abuse treatment facility.
Information obtained with this questionnaire provided a description of the sample and
determined group eligibility for hypotheses 1 and 2. See Appendix K.
Procedure
Training of Research Assistants
Because the principal investigator was residing in the United States when this
study was carried out, one data collection coordinator and four research assistants were
involved in the recruitment and administration of the assessment measures to participants
in Brazil. The data collection coordinator was responsible for overseeing the
implementation of the data collection procedures and ensuring consistency with the
research protocol. The coordinator had a Masters degree in mental health counseling
from Florida Atlantic University and was a licensed mental health counselor by the
Florida Department of Health with over 10 years of clinical experience. She was provided
with a copy of the research proposal, which included information about the purpose,
theoretical basis and methods of the study, as well as specific instructions for instrument
administration (see Appendix L).
The research assistants worked under the coordinator’s supervision and were
responsible for assisting her in all aspects of the data collection procedure. Three of them
had graduate degrees (in education, marketing, and vocational counseling) and had
experience with data collection prior to their collaboration with this study. One was
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completing a college degree in economy.
The coordinator and assistants were trained by the principal investigator during a
trip to Rio de Janeiro. The training consisted of two 2-hour meetings, during which the
coordinator and assistants (a) were provided with a detailed explanation of the purpose of
the study and all procedures involved in data collection, (b) were asked to complete all
assessment measures to become familiar with the research protocol, and (c) were
encouraged to ask questions and voice concerns about potential problems with the
recruitment of subjects and the administration of the protocols. In addition, the
coordinator and research assistants were supervised by the principal investigator during
their first administration of the assessment materials. They maintained regular
communication with the principal investigator by phone and e-mail during the entire data
collection phase to discuss any problems with the recruitment of subjects and instrument
administration.
Initially the research assistants were involved only in the recruitment and testing
of controls, but later participated in data collection at the substance abuse treatment
facilities as well, due to the coordinator being unable to continue her direct collaboration
with this project.
Data Collection
Clinical Sample
Contact with program directors of the Clínica Pater-Aldeia and Primeira Clínica
Popular do Estado do Rio de Janeiro was made by this investigator. A written
authorization for data collection was obtained prior to the recruitment of the subjects and
administration of the assessment measures.
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During group therapy sessions, patients were made aware of this study by their
own therapists, who asked for their voluntary and anonymous participation. All potential
subjects were fully informed about the purpose of the investigation, the procedures
involved, the risks and benefits associated with their participation, and their right to
withdraw from the study at any time. They were assured that their answers would be kept
confidential and those who agreed to participate were asked to sign an Informed Consent
Form.
Patients who agreed to participate in the study stayed in the group room after their
therapy session ended to complete the assessment materials. The instruments were
administered by either the data collection coordinator or one of the research assistants.
Even though data collection was performed outside of the United States, where the
Health Insurance Portability and Accountability Act (HIPAA) does not apply, attention
was paid to methods that insured patients’ privacy.
Non-Clinical Sample
Contact with leaders of the Igreja Congregacional em Vila Paraíso and the Igreja
Presbiteriana Betânia in Rio de Janeiro was made by this investigator. A written
authorization for data collection was obtained.
During regular church meetings, a brief announcement about the study was made
by the church leader and those interested in participating were instructed to meet with one
of the research assistants for additional information. Those who decided to meet with the
research assistants were fully informed about the purpose of the investigation, the
procedures involved, the risks and benefits associated with their participation, and their
right to withdraw from the study at any time. They were assured that their answers would
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be kept confidential and those who agreed to participate were asked to sign an Informed
Consent Form. Participants were then given the option to complete the assessment
materials at that time or schedule an appointment to meet with the research assistants at
another date.
All Participants
All participants, regardless of group membership, were administered the following
assessment measures: (1) the Brazilian-Portuguese version of the third edition of the Millon
Clinical Multiaxial Inventory (BP-MCMI-III), (2) the Brazilian-Portuguese version of the
Alcohol Use Disorders Identification Test (AUDIT), (3) a diagnostic questionnaire
(DSM-IV-TR), and (4) a demographic questionnaire.
Testing was typically done in groups of 5 to 10 participants and subjects were
administered the assessment materials in counterbalanced order to control for possible
order effects. Approximately half of the sample completed the assessment measures in
the following order: demographic questionnaire, BP-MCMI-III, diagnostic questionnaire,
and AUDIT. The other half completed the assessment measures in the following order:
demographic questionnaire, diagnostic questionnaire, AUDIT, and BP-MCMI-III.
The examiners followed the standard administration procedures (Appendix L)
with all subjects, except when participants did not have at least an 8th grade education (N
= 29). In those cases, examiners read the instructions and all questions to every one in the
group and waited until all participants had answered each question before moving to the
next. Standard administration involved reading the instructions and the first two questions
of each instrument to ensure that participants understood how to complete the measures,
and allowing them to complete the remaining questions at their own pace (N = 97).
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Participants who did not have at least an 8th grade education were mostly patients at the
First Popular Clinic of the State of Rio de Janeiro (26 participants), 2 were patients at the
Pater-Aldeia Clinic, and 1 was recruited through the Igreja Congregacional em Vila
Paraiso.
For testing the effect of procedure differences on the subjects’ test scores, 4 t-tests
were run using a dummy-coded education variable (1 = 8th grade education and above; 0
= below 8th grade education) as the independent variable. The dependent variables were
the subjects’ raw and base rate scores on the Alcohol Dependence and Drug Dependence
scales of the BP-MCMI-III. Because most participants who did not have a minimum of
8th grade education (97 percent of the total sample) were part of the clinical sample, only
clinical subjects were used for this comparison. The results were not significant,
indicating that procedure differences did not have an effect on the dependent variables.
Table 16 presents the results of the t-tests.

Table 16
Effect of Procedure Differences on the Dependent Variables
Variable
Alcohol Dependence: Raw
Drug Dependence: Raw
Alcohol Dependence: Base Rate
Drug Dependence: Base Rate

t

Df

p

.52
1.66
.31
1.18

73
73
73
73

.602
.102
.754
.240
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CHAPTER IV
Results
Preliminary Analyses
Effect of Test Order
Robust t-tests were used to examine the effect of test order on the dependent
variables. The results obtained were non-significant for both the Alcohol Dependence and
the Drug Dependence scales, indicating that the order by which the tests were completed
by the participants did not affect their BP-MCMI-III scores. Table 17 presents the results
of these tests.

Table 17
Effect of Test Order on the Dependent Variables (N = 126)
Variable
Alcohol Dependence: Raw
Drug Dependence: Raw
Alcohol Dependence: Base Rate
Drug Dependence: Base Rate

t

df

p

.46
1.12
1.11
1.03

123.94
122.78
121.75
123.77

.644
.265
.270
.305

Correlation between the Dependent Variables
Pearson correlations between the BP-MCMI-III Alcohol Dependence and Drug
Dependence scales were calculated. For raw scores, the correlation was .85; and for base
rate scores it was .73. They were both found to be significant at the .01 level (two-tailed).
Effect of the Demographic Variables on the Dependent Variables
As noted in the methods section, clinical and control groups were unequal on all
demographic variables (except age for hypotheses 1, 2 and 4; and marital status for
hypothesis 3). If the relationship between the demographic variables and the dependent
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variables are statistically significant, this could pose a threat to the internal validity of the
study.
Pearson correlations between the subjects’ BP-MCMI-III scores on the Alcohol
Dependence and Drug Dependence scales were run with the demographic variables to
determine the need for statistically controlling their effect during hypotheses testing.
Nominal variables were converted into dummy-coded variables to allow correlations to
be computed [(1 = Protestant; 0 = other) for religion; (1 = married; 0 = other) for marital
status; and (1 = employed; 0 = unemployed) for occupation]. Correlations were found to
be significant for Gender, Marital Status, Education, Religion, History of Alcohol
Treatment, History of Drug Treatment, and Frequency of Drinking. Table 18 presents the
correlations for both raw and base rate BP-MCMI-III scores.

Table 18
Correlations between the Subjects’ Raw and Base Rate Scores on the BP-MCMI-III
Substance Dependence Scales with Demographic Variables
Variable
Age
Gender
Marital Status
Occupation
Education
Religion
Alcohol Tx Hx
Drug Tx Hx
Frequency of Drinking

Alcohol/Raw
.04
.35**
.17
.13
.55**
.67**
.45**
.39**
.71**

*. Correlation is significant at the .05 level (2-tailed)
**. Correlation is significant at the .01 level (2-tailed)

Drug/Raw

Alcohol/BR

.09
.40**
.23*
.13
.55**
.67**
.45**
.47**
.60**

.05
.32**
.18*
.13
.52**
.63**
.38**
.34**
.65**

Drug/BR
.16
.26**
.28**
.11
.47**
.61**
.39**
.41**
.57**
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Hypotheses Testing
The analysis of covariance (ANCOVA) is a statistical test that can be used when
there is need for elimination of systematic bias (Stevens, 1990), as is the case in this
study. For testing hypotheses 1, 2, 3 and 4, eight analyses of covariance (ANCOVAs)
were run using gender, education, history of alcohol treatment, history of drug treatment,
frequency of drinking, and dummy coded variables for marital status (1 = married; 0 =
other) and religion (1 = Protestant; 0 = other) as covariates. The independent variables for
each analysis were dichotomous (two groups = clinical, control) and the dependent
variables were the BP-MCMI-III raw and base rate scores for the Alcohol Dependence
and Drug Dependence scales. Hypothesis 5 was tested by performing a t-test to determine
the significance of the correlation between AUDIT scores and BP-MCMI-III scores.
Hypothesis 1
It was expected that clinical participants would have a significantly higher raw and
base rate score than controls on the Alcohol Dependence scale of the Brazilian-Portuguese
version of the Millon Clinical Multiaxial Inventory-III (BP-MCMI-III), when clinical and
control groups were defined based on whether individuals were receiving or not receiving
treatment for alcohol-related problems at the time of testing.
The diagnostic validity of the BP-MCMI-III Alcohol Dependence scale was
supported by the results of the ANCOVAs when both raw (F = 18.19; df = 1, 111; p <
.05) and base rate scores (F = 7.79; df = 1, 111; p < .05) were used in the analyzes. The
scores of patients receiving treatment for alcohol-related problems at the time of testing
(N = 60) were significantly higher than the scores of non-clinical participants (N = 51).
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The magnitude of the effect (partial eta squared) reached .15 for raw and .07 for base rate
scores.
Hypothesis 2
It was expected that clinical participants would have a significantly higher raw and
base rate score than controls on the Drug Dependence scale of the Brazilian-Portuguese
version of the Millon Clinical Multiaxial Inventory-III (BP-MCMI-III), when clinical and
control groups were defined based on whether individuals were receiving or not receiving
treatment for drug-related problems at the time of testing.
The diagnostic validity of the BP-MCMI-III Drug Dependence scale was also
supported by the results of the ANCOVAs when both raw (F = 70.38; df = 1, 99; p < .05)
and base rate scores (F = 23.51; df = 1, 99; p < .05) were used in the analyzes. The scores
of patients receiving treatment for drug-related problems (N = 48) were significantly
higher than the scores of non-clinical participants (N = 51). The magnitude of the effect
(partial eta squared) reached .44 for raw and .21 for base rate scores.
Hypothesis 3
For hypothesis 3, groups were defined based on the presence of positive (clinical)
versus negative (control) DSM-IV-TR diagnoses. Subjects who gave 3 or more “yes”
responses for items 1 through 7 of the Diagnostic Questionnaire (alcohol use questions)
met the DSM-IV-TR diagnostic criteria for alcohol dependence; those who gave 1 or
more “yes” responses for items 8 through 11 met criteria for alcohol abuse (see Appendix
J). It was expected that individuals diagnosed with alcohol abuse or dependence based on
DSM-IV-TR criteria would have significantly higher raw and base rate scores than controls
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on the Alcohol Dependence scale of the Brazilian-Portuguese version of the Millon Clinical
Multiaxial Inventory-III (BP-MCMI-III).
The diagnostic validity of the BP-MCMI-III Alcohol Dependence scale was also
supported by the results of the ANCOVAs when group eligibility was defined by the
presence of positive versus negative DSM-IV-TR diagnoses, for both raw (F = 10.24; df
= 1, 121; p < .05) and base rate scores (F = 6.98; df = 1, 121; p < .05). Participants who
scored positive for alcohol-related problems on the Diagnostic Questionnaire (DQ)
obtained higher raw and base rate scores on the BP-MCMI-III Alcohol Dependence scale
than those who scored negative on the DQ. The magnitude of the effect (partial eta
squared) reached .08 for raw and .06 for base rate scores.
Hypothesis 4
For hypothesis 4, groups were also defined based on the presence of positive
(clinical) versus negative (control) DSM-IV-TR diagnoses. Subjects who gave 3 or more
“yes” responses for items 1 through 7 of the Diagnostic Questionnaire (drug use
questions) met the DSM-IV-TR diagnostic criteria for drug dependence; those who gave
1 or more “yes” responses for items 8 through 11 met criteria for drug abuse (see
Appendix J). It was expected that individuals diagnosed with drug abuse or dependence
based on DSM-IV-TR criteria would have a significantly higher raw and base rate score
than controls on the Drug Dependence scale of the Brazilian-Portuguese version of the
Millon Clinical Multiaxial Inventory-III (BP-MCMI-III).
The diagnostic validity of the BP-MCMI-III Drug Dependence scale was also
supported by the results of the ANCOVAs when group eligibility was defined by the
presence of positive versus negative DSM-IV-TR diagnoses, for both raw (F = 61.83; df
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= 1, 121; p < .05) and base rate scores (F = 22.99; df = 1, 121; p < .05). Participants who
scored positive for drug-related problems on the Diagnostic Questionnaire (DQ) obtained
higher raw and base rate scores on the BP-MCMI-III Drug Dependence scale than those
who scored negative on the DQ. The magnitude of the effect (partial eta squared) reached
.36 for raw and .17 for base rate scores.

Table 19 summarizes the results of the

ANCOVAs for hypotheses 1 through 4.

Table 19
Results of the ANCOVAs for Hypotheses 1 through 4
F

Hypothesis 1
Hypothesis 2
Hypothesis 3
Hypothesis 4

η²

p

Raw
Scores

Base
Rates

Raw
Scores

Base
Rates

Raw
Scores

Base
Rates

18.19
70.38
10.24
61.83

7.79
23.51
6.98
22.99

.000
.000
.002
.000

.006
.000
.009
.000

.15
.44
.08
.36

.07
.21
.06
.17

Hypothesis 5
It was expected that there would be a significant positive correlation between
subjects’ scores on the Alcohol Dependence scale of the Brazilian-Portuguese version of the
Millon Clinical Multiaxial Inventory-III (BP-MCMI-III) and scores on the Alcohol Use
Disorders Identification Test (AUDIT).
Pearson correlations between the AUDIT and the BP-MCMI-III Alcohol
Dependence scale were obtained using both raw (r = .81) and base rate scores (r = .72).
The results showed strong positive correlations that were significant at the .01 level.
Findings indicate that these two scales are measuring similar constructs and support the
construct validity of the BP-MCMI-III Alcohol Dependence scale.
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Post Hoc Analyses
Validity Indices of the BP-MCMI-III Alcohol and Drug Dependence Scales
Diagnostic validity indices were computed for the BP-MCMI-III Alcohol
Dependence and Drug Dependence scales at cut-offs of 75, 80 and 85. The presence of
positive versus negative DSM-IV-TR diagnoses, determined by the subjects’ scores on
the Diagnostic Questionnaire, was considered the “gold standard” to which diagnoses
made by the BP-MCMI-III were compared. Table 20 presents the number of positive and
negative cases determined by the DSM-IV-TR criteria (true positives and true negatives)
and the number of positive and negative cases identified by the BP-MCMI-III (test
positives and test negatives).

Table 20
Diagnoses made by the DSM-IV-TR Criteria and by the BP-MCMI-III
DSM-IV-TR

BP-MCMI-III
(BR 75)

BP-MCMI-III
(BR 80)

BP-MCMI-III
(BR 85)

Positive

Negative

Positive

Negative

Positive

Negative

Positive

Negative

Alcohol

66

60

73

53

59

67

51

75

Drug

54

72

53

73

46

80

39

87

Conceptual formulas used to calculate sensitivity, specificity, positive predictive
power (PPP), negative predictive power (NPP), overall diagnostic power (DxP) and
prevalence of the BP-MCMI-III substance dependence scales are presented on Table 21.
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Table 21
Conceptual Formulas for Calculating the Operating Characteristics of a Testa
Disorder
Test Result

Present

Absent

Positive

A

B

A+B

Negative

C

D

C+D

A+C

B+D

N

Totals
Index

Definitionb

Formula

Sensitivity
Pr (Test + │ Disorder +)
A / (a + c)
Specificity
Pr (Test - │Disorder - )
D / (b + d)
Positive Predictive Power
Pr (Disorder +│ Test + )
A / (a + b)
Negative Predictive Power
Pr (Disorder - │ Test - )
D / (c + d)
Overall Diagnostic Power
Proportion correctly classified
(a + d) / N
Prevalence
Proportion of subjects with the disorder
(a + c) / N
a
In Gilbertini et al. (1986).
b
Definitions are expressed in terms of conditional probabilities. The definitions for sensitivity would read:
“the probability that the test is positive given the disorder is present.”

Incremental validities for positive test diagnoses (IPPP) were defined as the
difference between the Alcohol Dependence and Drug Dependence scales’ positive
predictive powers and the prevalence of alcohol and drug problems in the sample,
respectively. Incremental validities for negative test diagnoses (NPPP) were defined as
the difference between the Alcohol Dependence and Drug Dependence scales’ negative
predictive powers and their corresponding prevalence. Kappa values were determined by
finding the proportion of agreements (adjusted for chance agreements) between BPMCMI-III and DSM-IV-TR classifications. Additional validity indices that can be
calculated independently from cut-off scores – Effect Size and the area under the ROC
curve (AUC) – were also computed. The results are summarized on Table 22.

64
Table 22
Diagnostic Validity Indices of the BP-MCMI-III Alcohol Dependence and Drug
Dependence Scales at 75, 80 and 85 Cut-Offs
Alcohol Dependence Scale

Sensitivity
Specificity
PPP
NPP
DxP
IPPP
INPP
Kappa
Prevalence
Effect Size
AUC

Drug Dependence Scale

BR 75

BR 80

BR 85

BR 75

BR 80

BR 85

.94
.82
.85
.93
.88
.33
.41
.76
.52
1.89
.94

.80
.90
.90
.81
.85
.38
.29
.70
.52
1.89
.94

.71
.93
.92
.75
.82
.40
.23
.64
.52
1.89
.94

.82
.88
.83
.86
.85
.40
.43
.69
.43
1.90
.94

.72
.90
.85
.81
.83
.42
.38
.64
.43
1.90
.94

.65
.96
.90
.78
.82
.47
.35
.62
.43
1.90
.94

The area under ROC (receiver operating characteristic) curves, also known as
AUC, was determined by plotting true positive rates against false positive rates of alcohol
and drug problems at different cutoff points. Figure 1 and 2 provide a visual
representation of AUC for both the Alcohol Dependence and Drug Dependence scales.
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Figure 1:

AUC for the Alcohol Dependence Scale of the BP-MCMI-III
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Figure 2:

AUC for the Drug Dependence Scale of the BP-MCMI-III
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Validity Indices of the Brazilian AUDIT
The operating characteristics of the revised translation of the AUDIT used in this
study were not previously reported in the literature. Validity indices were calculated with
this sample (N = 126). The results are presented on Table 23.

Table 23
Operating Characteristics of the Revised Brazilian AUDIT at 7, 8, 9 and 10 Cut-Offs
AUDIT Cut-Scores

Sensitivity
Specificity
PPP
NPP
DxP
IPPP
INPP
Kappa
Prevalence

7

8

9

10

.95
.93
.94
.95
.94
.42
.43
.89
.52

.95
.95
.95
.95
.95
.44
.44
.91
.52

.95
.97
.97
.95
.96
.45
.44
.92
.52

.92
.97
.97
.92
.94
.45
.41
.89
.52
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Figure 3: AUC for the Revised Brazilian AUDIT
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CHAPTER V
Discussion
Hypotheses
This study examined the validity of the Brazilian-Portuguese version of the Millon
Clinical Multiaxial Inventory-III (BP-MCMI-III) Alcohol Dependence and Drug
Dependence scales for detecting alcohol- and drug-related problems in a Brazilian sample
composed of clinical and non-clinical subjects.
It was hypothesized that clinical participants would obtain significantly higher raw
and base rate scores than controls on the Alcohol Dependence scale of the BP-MCMI-III
when groups were defined based on two criteria: (a) whether individuals were receiving or
not receiving treatment for alcohol-related problems at the time of testing (Hypothesis 1),
and (b) whether they met the DSMI-IV-TR criteria for either alcohol abuse or dependence
(Hypothesis 3).
It was also hypothesized that clinical participants would obtain significantly higher
raw and base rate scores than controls on the Drug Dependence scale of the BP-MCMI-III
when groups were defined based on: (a) whether individuals were receiving or not receiving
treatment for drug-related problems at the time of testing (Hypothesis 2), and (b) whether
they met the DSM-IV-TR criteria for either drug abuse or dependence (Hypothesis 4).
Furthermore, it was expected that there would be a significant positive correlation
between participants’ scores on the Alcohol Dependence scale of the BP-MCMI-III and
scores on the Alcohol Use Disorders Identification Test (AUDIT) (Hypothesis 5).
All hypotheses were supported by the data. Findings indicated that the BPMCMI-III Alcohol Dependence scale can identify Brazilians with alcohol-related
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disorders among those who do not have problems related to alcohol consumption; and
that the BP-MCMI-III Drug Dependence scale can identify Brazilians with drug-related
disorders among those who do not have problems related to drug usage. Furthermore, a
high correlation between the BP-MCMI-III alcohol dependence scale and the AUDIT
was found, which provides additional support for the validity of this scale.
Diagnostic Validity Indices
Base Rate scores for the MCMI-III are anchored to the prevalence rate of
disorders in the psychiatric population. Prevalence rates obtained with the clinical sample
used in the development phase of the instrument, as well as information derived from
various epidemiological studies in the United States, were used to develop the criteria
utilized to create the base rate scores for the original MCMI-III. As they apply to the
clinical syndrome scales, cut-off scores of 75 and above on the MCMI-III indicate the
presence of a syndrome; while scores of 85 and above indicate the prominence of a
syndrome.
The sample used in the present study was homogeneous when compared to the
hundreds of participants with various psychiatric disorders that were included in the
sample utilized for the development of the MCMI-III. Given the fact that prevalence was
.52 for alcohol-related problems and .43 for drug related-problems in the present sample,
these indices are likely to be non-representative of the prevalence of substance abuse
disorders in the Brazilian psychiatric population at large and, therefore, inappropriate for
deriving new base rate scores for the BP-MCMI-III.
Without computing new base rates for the BP-MCMI-III, we can say that a 75
cut-off for these scales is perhaps the most effective cut-score given this sample. At the
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cut-score of 75, the BP-MCMI-III alcohol and drug dependence scales performed
approximately equal or better than the MCMI-III (at cut-score of 85) for most validity
indices when the 1994 MCMI-III data set was used for comparison. The BP-MCMI-III
alcohol and drug dependence scales performed approximately equal or somewhat worse
than the MCMI-III (at cut-score of 85) for most validity indices when the 1997 MCMI-III
data set was used for comparison. These results are not surprising given the fact that there
is concern about the possibility of underestimation of the validity of the MCMI-III based
on the 1994 validity data and the potential for overestimation based on the 1997 data set
(Hsu, 2002). A more detailed discussion about the 1994 and 1997 MCMI-III validity
studies of the MCMI-III can be found in the literature review section of this paper. Table
24 and 25 present validity indices for the MCMI-III and the BP-MCMI-III at 75 and 85
cut-offs.
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Table 24
Comparative Table of Validity Indices for the MCMI-III and BP-MCMI-III Alcohol
Dependence Scales
MCMI-III

Sensitivity
Specificity
PPP
NPP
DxP
IPPP
INPP
Kappa
Prevalence
Effect Size
AUC

BP-MCMI-III

1994a

1997a

BR 75

BR 85

.73**
.86**
.42**
.96**

.80*

.30***
.08***
.45***
.12**
1.68***
.88***

.71***
.13***
.81***
.17*
2.85***
.98***

.94
.82
.85
.93
.88
.33
.41
.76
.52
1.89
.94

.71
.93
.92
.75
.82
.40
.23
.64
.52
1.89
.94

.88*

a

Statistic calculated using cut-score of 85.
*In Millon, 1997; **In Restlaff, 1996; and ***In Hsu, 2002.

Table 25
Comparative Table of Validity Indices for the MCMI-III and BP-MCMI-III Drug
Dependence Scales
MCMI-III

Sensitivity
Specificity
PPP
NPP
DxP
IPPP
INPP
Kappa
Prevalence
Effect Size
AUC
a

BP-MCMI-III

1994 a

1997 a

BR 75

BR 85

.52**
.95**
.47**
.96**

.82*

.39***
.04***
.47***
.08**
1.67***
.88***

.82***
.09***
.86***
.11*
3.34***
.99***

.82
.88
.83
.87
.85
.41
.44
.69
.43
1.90
.94

.65
.95
.90
.78
.82
.47
.36
.62
.43
1.90
.94

.93*

Statistic calculated using cut-score of 85.
*In Millon, 1997; **In Restlaff, 1996; and ***In Hsu, 2002.
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Sensitivity and Specificity
Specificity values for the alcohol dependence and drug dependence scales were
above .80. Sensitivity was above .90 for alcohol dependence and above .80 for drug
dependence. This indicates that both scales were sensitive for detecting positive
disordered cases in the sample, while being specific enough to identify as positive those
cases that truly had substance abuse disorders. As noted in the literature review section,
specificity and sensitivity are usually considered to be independent of the prevalence of
the disorder in the sample; in other words, a test should identify the same proportion of
disordered cases across samples. However, calculating these two indices requires that one
knows which cases in the sample really have the disorder the instrument is supposed to
detect.
In the present study, true positive and true negative cases of alcohol- and drugrelated disorders were determined by the subjects’ scores on a self-report symptom
checklist, which contained 11 yes-no questions about substance use patterns, each
corresponding to a specific diagnostic criterion listed under the DSM-IV-TR diagnostic
code. Separate forms for alcohol and drug abuse/dependence were used.
This leads to a question regarding the reliability and validity of the DSM-IV-TR
and of diagnostic criteria checklists for accurately diagnosing substance abuse disorders.
Because there is much overlap between the so-called “mental disorders,” critics of the
DSM argue that categorical systems are ineffective and can work optimally only when
members of a diagnostic class are homogeneous, when there are clear boundaries
between classes, and when different classes are mutually exclusive (APA, 1994).
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Despite its limitations, the DSM classification system has been recognized as a
major improvement over diagnostic methods that rely on a clinician’s subjective
interpretation of presented symptoms. A major contribution of the DSM is the
development of specific criteria for classification of disorders, which allowed for the
development of structured diagnostic interviews and increased the reliability of diagnoses
made across examiners (Spiegel, 2005).
Structured diagnostic interviews are commonly used in substance abuse research
and are generally considered reliable instruments for use with both clinical samples and
the general population (Grant and Towle, 1990; Grant, 1997). The self-report measure
that was used in this study is a reduced version of the Alcohol Use Disorder and
Associated Disabilities Interview Schedule (AUDADIS), one of the most widely used
diagnostic instruments of this type.
Predictive Power and Overall Diagnostic Power Indices
Predictive power indices (PPP and NPP) represent the probability that a disorder
is present or absent given the results of the test. Compared to specificity and sensitivity,
PPP is usually considered more useful to the clinician making decisions about individual
patients (Gibertini et al, 1986; Retzlaff, 1996).
At a 75 cut-off, the BP-MCMI-III substance dependence scales’ positive
predictive powers (PPPs) were higher (.85 for alcohol and .83 for drug dependence) than
those reported for the MCMI-III 1994 data set (.42 and .47) and somewhat lower than
those reported for the 1997 data set (.88 and .93). Negative predictive power (NPP) was
.93 for alcohol dependence and .87 for drug dependence for the BP-MCMI-III; and .96
for both MCMI-III substance dependence scales with the 1994 sample. At an 85 cut-off
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the BP-MCMI-III gains more positive predictive power for both scales, but negative
predictive powers drop below .80.
Overall Diagnostic Power (DxP) provides a global index of a test’s overall
classification accuracy. Generally speaking, this index is a combination of the two
predictive power indices (PPP and NPP) and reflects the proportion of correctly classified
subjects according to the presence or absence of a disorder. The BP-MCMI-III overall
diagnostic power was above .80 for both substance dependence scales at the 75 and 85
cut-offs. DxP for the original MCMI-III was not reported in the literature.
Chance-Adjusted Indices
Hsu (2002) argued that predictive power indices (PPP and NPP) can be
misleading, despite the great importance they have been assigned in the literature. A
major limitation of PPP and NPP is that, in the absence of any association between test
scores and the presence or absence of the disorder, they can be expected to be equal to the
prevalence of the disorder in the sample. In other words, it is only when a test shows
predictive power indices that exceed prevalence, that one can say that diagnoses made
based on the test are better than chance.
Hsu (2002) demonstrated that Incremental Validity of Positive Test Diagnoses
(IPPP) and Incremental Validity of Negative Test Diagnoses (INPP) can prevent
misinterpretation of PPP and NPP, by proving information about how much better than
chance a test correctly identifies positive and negative cases of a disorder.
IPPPs obtained with the present sample for the BP-MCMI-III substance
dependence scales were similar to those reported for the MCMI-III 1994 data set at a 75
cut-off (.33 for the alcohol dependence and .41 for drug dependence) and somewhat
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higher at an 85 cut-off (.40 and .47, respectively). On the other hand, compared to the
IPPPs obtained with the MCMI-III 1997 data set (.71 and .82 for alcohol and drug
dependence respectively), the IPPPs for the BP-MCMI-III substance dependence scales
were much lower.
INPPs obtained for the BP-MCMI-III at a 75 cut-off were .41 for alcohol
dependence and .44 for drug dependence. They were somewhat lower at an 85 cut-off
(.23 and .36 for alcohol and drug dependence, respectively), but still much higher than
the same indices reported for both the 1994 (.08 for alcohol dependence and.04 for drug
dependence) and 1997 (.13 for alcohol dependence and .09 for drug dependence) MCMIIII samples.
Unlike IPPP and INPP, which provide separate chance-adjusted measures of
either positive or negative test diagnoses, Cohen’s Kappa can be used to measure the
combined chance-adjusted diagnostic validities of both positive and negative test
diagnoses (Hsu, 2002). Kappa values obtained with the present sample for the BPMCMI-III substance dependence scales at a 75 cut-off are .76 and .69, which are higher
than Kappas obtained with the 1994 MCMI-III data set (.45 for alcohol dependence and
.47 for drug dependence) and lower than Kappas obtained with the 1997 MCMI-III
sample (.81 for alcohol dependence and .86 for drug dependence). At an 85 cut-off,
Kappa values are somewhat lower for the BP-MCMI-III alcohol and drug dependence
scales (.64 and .62, respectively).
Cohen’s Effect Size and AUC
A limitation of the use of PPP, NPP, IPPP, INPP, and Kappa as diagnostic
validity indices is that these statistics are dependent on base rates. Cohen’s effect size, on
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the other hand, is free from the effects of cut scores and prevalence, and can be used as a
measure of the relative ability of a test to discriminate between groups (Hsu, 2002).
Cohen’s effect size was 1.89 for the BP-MCMI-III alcohol dependence scale and 1.90 for
the drug dependence scale, which are considered large (Cohen, 1988).
The area under receiver operating characteristics curves (AUC) can also be used
as a validity index that is free from the effects of cut scores and prevalence. According to
Hsu (2002), this index “reflects the probability that a randomly selected person from one
population will have a scale score that exceeds that of a randomly selected person from
the other population.” AUC for the BP-MCMI-III substance dependence scales were both
.94, slightly larger than the reported AUCs for the 1994 MCMI-III study and slightly
smaller than the AUCs for the 1997 study.
Concluding Remarks
Diagnostic validity indices obtained with the present sample provided additional
support for the validity of the BP-MCMI-III substance dependence scales for detecting
alcohol- and drug-related disorders among Brazilians. Generally speaking, the diagnostic
efficiency values obtained with this sample were approximately equal or better than those
reported for the MCMI-III when the 1994 MCMI-III data was used for comparison;
values were approximately equal or somewhat worse than those reported for the MCMIIII when compared to the 1997 data set. The BP-MCMI-III diagnostic efficiency values
obtained with the present study were consistent with the results of previous validity
studies with the MCMI-III. Present findings suggest that the BP-MCMI-III can be a
useful diagnostic tool.
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Internal and External Validity of the Study
Potential threats to internal validity (associated with group differences in terms of
gender, marital status, education, religion, history of alcohol treatment, history of drug
treatment and frequency of drinking) were addressed with the use of ANCOVAs during
hypotheses testing. Although ANCOVAs can not completely remove the potential for
selection bias with intact groups, this method is considered to be a reasonable solution for
the problem of unequal groups if caution is exercised when interpreting the results
(Stevens, 1990). Given the limitations of ANCOVAs for controlling the potential for
selection bias in non-randomized studies, the conclusions about this study are presented
tentatively.
The fact that the sample was composed of Brazilians residing in Brazil is one of
the strengths of this study. If data had been collected in the United States, the
participants’ understanding of individual test items potentially would have been affected
by acculturation, which in turn would have limited the external validity of the results.
Nevertheless, the results of this study must be interpreted in the context of the
characteristics of the sample it used. Participants were recruited from low-income and
middle-income suburban areas in Rio de Janeiro, the second largest metropolitan region
in Brazil. Although it is unlikely that Brazilians residing in other parts of Brazil would
have responded differently to the assessment measures, it is possible that regional
differences in the use of the Portuguese language may have affected the results.
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Future Directions
Findings supported the validity of the BP-MCMI-III substance dependence scales
for detecting substance-related problems among Brazilians. Future studies should focus
on examining the diagnostic efficiency of the scales with a sample that includes a more
heterogeneous psychiatric population, so that new base rates can be computed. The
validity of other BP-MCMI-III scales should also be examined so that the instrument’s
overall diagnostic utility can be ascertained.
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The Translation of the MCMI-III into Brazilian-Portuguese:
Preliminary Findings
Cristina L. G. P. Magalhaes, Eduardo P. Magalhaes,
Alfred H. Sellers, & John Lewis
Nova Southeastern University
Ft. Lauderdale, FL, USA
A Brazilian-Portuguese version of the MCMI-III was developed to be
used in future studies that will examine cross-cultural aspects of
personality and psychopathology in Brazil and the United States. This
paper presents the translation methodology for this endeavor and the
preliminary statistical results. The linguistic equivalency of the two
versions was evaluated with a group of bilingual individuals in the
United States. Item-by-item agreement rates ranged from 44% to
100% (Median=90.4%). The median correlation between English and
Brazilian-Portuguese versions across the 27 scales was .83 (range =
.07 to .96). These results are seen as encouraging and suggest
consistency of measurement across cultures.

The Millon Clinical Multiaxial
Inventory (MCMI) is currently one of the
most popular instruments used for the
assessment of adult psychopathology in the
United States (Choca & Van Denburg,
1997). It has inspired a growing number of
studies since its first publication in 1977 and
now, in its third version, occupies a central
place in many clinical settings (Craig, 1997).
Several translations and adaptations of the
Millon Inventories to other languages have
been reported in the literature and are
currently being used in many other countries
(e.g. Sloore & Derksen, 1997; Mortensen &
Simonsen, 1990; Luteijn, 1990).
According to Escovar (1997), the
MCMI is particularly appropriate for crosscultural applications. Because of its solid
theoretical foundation, the MCMI allows for
the assessment of personality disorders and
clinical syndromes at a basic, theoretical
level. Moreover, the MCMI’s consonance
with the DSM-IV allows for the
interpretation and reporting of results
according to the current psychiatric

nosology used in many countries (Millon &
Millon, 1997).
Due to the demand for psychological
instruments that can be appropriately used
with Portuguese speaking individuals of
Brazilian heritage, we conducted a
translation of the MCMI-III into BrazilianPortuguese. Only a small number of
instruments are now available for clinical
and research purposes with a Brazilian
population and a good part of these
instruments are based on projective
diagnostic approaches. There is a need for
self-report measures in Brazilian-Portuguese
that are reliable, easy to use in a variety of
clinical settings, and up-to-date with the
most current theories of personality and
psychopathology.
The current literature provides several
guidelines for the translation and adaptation
of psychological instruments for crosscultural use (see Van de Vijver &
Hambleton, 1996, for a comprehensive
description of potential sources of bias and
recommended
practices).
The
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translation/back translation procedure is
considered standard by most test translators
and is used to evaluate whether original item
content is preserved or changed in the
translated version. In this procedure, the
translated items are translated back into the
source language and then compared with the
original version of the instrument to check
for content discrepancies. Although this
method seems to be a common procedure
among test translators (e.g. Sloore &
Derksen 1997; Saito, Nomura, Noguchi &
Tezuka, 1996), the literature advises that it
should be used with caution. According to
Geisinger (1994), research has found that
test translators, when knowing that their
work will be subject to back translation, tend
to use wording that ensures a good match
between back translation and original
version, rather than one that accurately
reproduces the original content of the items.
Moreover, readability and fluency of the text
tend to be neglected when back translation
procedures are employed (Van de Vijver &
Hambleton, 1996). Other authorities in the
field have concluded, however, that back
translation is a valuable tool despite its
limitations and should be implemented by
test translators (Butcher, 1996).
As an alternative technique to back
translation, the use of revisers has been
suggested by Geisinger (1994). He
recommended having a group of individuals
carefully review all translated items, make
comments about the quality of the
translation, and discuss with test translators
alternative wording for problem-items. This
review process is also expected to minimize
the potential for translation bias as well as to
enhance the quality of the final product.
Another recommended practice is the
use of a committee approach to translation
(Butcher, 1998; Sloore & Derksen 1997;
Saito et al, 1996; Butcher, 1996). Rather
than having only one person translate the
instrument, the literature suggests having
members of a translation team make the
translation of all items independently and
later integrate their work into one version on
the basis of discussion. The committee
members should be not only fluent in both

languages but also knowledgeable about
both cultures and the constructs being
measured (Geisinger, 1994).
Finally, in order to further evaluate
the linguistic accuracy of a translated
instrument, a pilot study using bilingual
individuals should be carried out (Butcher,
1998; Sloore & Derksen, 1997; Butcher,
1996; Saito et al., 1996). In this method,
both versions are administered to a sample
of bilingual subjects to detect problems with
particular items and evaluate the reliability
of the instrument across versions. Frequent
discrepancies between same items are
expected to indicate possible translation
problems and would suggest the need for
further refinement of the translated item.
The correlation coefficients obtained are
expected to approximate the test-retest
reliability coefficients reported in the
literature for the original version of the
instrument.
The purpose of the present paper is to
describe the methodology used for the
translation of the MCMI-III into BrazilianPortuguese and to present the bilingual pilot
results. As noted above, correlations are
expected to approximate the test-retest
reliability of the MCMI-III. Further studies
will be required to evaluate the
psychometric properties of the new
instrument (Paunonen & Ashton, 1998) and
its validity for use with a Brazilian
population. Validity-threatening factors
related to the construct being measured
(construct bias) and to instrument
administration (method bias) should also be
examined in the future to ensure appropriate
clinical and research use (Van de Vijver &
Hambleton, 1996).
Method
Translation Procedures
Our research team reviewed the
translation practices recommended in the
literature (Butcher, 1998; Butcher, 1996;
Van de Vijver & Hambleton, 1996;
Geisinger, 1994) and considered the
expertise of others who have translated tests
(e.g., Sloore & Derksen, 1997; Saito et al,
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1996) before initiating the translation of the
MCMI-III into Brazilian- Portuguese. A
combination of the practices discussed in the
introduction was deemed appropriate for our
study.
Initial Translation and Revision
A committee approach was used in
which the initial translation was conducted
independently by each member of the
committee and then integrated on the basis
of discussion. This committee consisted of
two bilingual Brazilians with cross-cultural
experience (two of the authors). Both had
more than 10 years of clinical experience
and were familiar with the content of the
MCMI-III.
The initial translation was then revised
by two research assistants who were selected
to participate in this project due to their
extensive experience in both cultures and
their knowledge of English and BrazilianPortuguese grammar. One reviser was an
American who had spent more than 15 years
working in Brazil and fully comprehended
the nuances of both languages. The second
reviser was a Brazilian who had been
studying and working in the United States
for 8 years (she currently works as a mental
health counselor and professional translator
in Broward County, Florida, USA). Because
the revisers were not familiar with the
content of the MCMI-III, their suggestions
were analyzed by the translation committee
who made the necessary adjustments to the
items before submitting them to the back
translation procedure.
When working on the items
independently, the translation committee
and the revisers were instructed to keep
several principles in mind: (1) if possible,
maintain the original wording and sentence
construction; (2) if necessary, modify the
wording and/or sentence construction
making changes as minimal as possible; (3)
try to use words and sentences that are easy
to understand; (4) if there is more than one
way an item can be translated, choose the
most simple one; (5) if necessary, use
explanatory
words/sentences
within

parenthesis to clarify words that have
ambiguous meaning.
Back Translation
Back translation was conducted by
another Brazilian research assistant with
extensive experience in both cultures (more
than 20 years working in the United States).
The back translated items were latter
compared to the original items by an
American research assistant who had no
knowledge
of
Portuguese.
When
discrepancies were found between back
translated items and their correspondent
items in the original version, the translation
committee and the back translator worked
together to detect the reason for the
problems, generate alternative formulations,
and prepare the final version used in the
bilingual retest study.
Bilingual Retest Strategy
Participants
Potential subjects were recruited from
the community on the basis of their
availability. They were contacted informally
through schools, churches, and businesses
that serve the Brazilian community in Dade
and Broward Counties (Florida, USA). They
were informally approached by the
investigators and invited to participate in the
study by responding anonymously to the
assessment materials. At this time they
received a brief explanation of the purpose
of the study and were assured of their
anonymity. Those who volunteered were
scheduled for a first interview with one of
the researchers.
During this first interview all
volunteers were fully informed about risks
and benefits associated with their
participation, their right to withdraw from
the study at any time, and the procedures
involved, including those related to ensuring
their anonymity. Those who agreed to
participate were asked to sign an Informed
Consent Form. All subjects were treated in
accordance with the ethical guidelines of the
American Psychological Association.
Criteria for inclusion in this study were:
(1) subject’s willingness to participate; (2)
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above 18 years of age; (3) above 8 years of
education; and (4) ability to speak and read
English and Brazilian-Portuguese. Subjects
were excluded from the study if they scored
below the 8th Grade level on the reading
subtest of the Wide Range Achievement
Test - 3rd Ed. (WRAT-III; Wilkinson,
1993).
A total number of twenty-one
Brazilian individuals fluent in BrazilianPortuguese and English volunteered for this
study. From this group, four volunteers
failed to appear for the second interview,
two did not meet criteria for inclusion in the
study, and six were not able to complete
retest in time to be included in this report.
The remaining participants were 5 males and
4 females with ages ranging from 34 to 58
(Mean = 41.7) and years of education
ranging from 10 to 22 (Mean = 12.7).
Instrumentation
Millon Clinical Multiaxial Inventory III. The MCMI-III (Millon, 1994) is a 175item instrument composed of 11 clinical
personality scales, 3 severe personality
pathology scales, 7 clinical syndrome scales,
3 severe syndrome scales, and 4 modifying
indices scales. Due to the norming of the
MCMI-III on psychiatric patients, base rates
(BR) are employed rather than standard
scores. A BR score of > 75 on a given scale
indicates that feature is present in the
individual's personality, while a BR score of
> 85 indicates that feature is prominent in
the composition of their personality.
Strengths of the MCMI-III include its
norming on a psychiatric population, its
brevity, and its ease of administration.
Moreover, the Millon inventories appeal to
many professionals as they define
personality traits using nomenclature with
which clinicians are accustomed (Choca &
Van Denburg, 1997; McCabe, 1984).
According to Millon (1994), internal
consistency (alpha) coefficients exceed .80
for 20 of the 26 scales. Also, the median
stability coefficient, based on two test
administrations between five and 14 days
apart, was .91. Regarding validity, Millon
reported that correlations between scale BR

scores and collateral instruments (e.g., BDI,
MMPI-2, SCL-90-R) were generally
favorable.
Wide Range Achievement Test - III.
The WRAT-III has one level for ages 5-75.
There are three forms (blue, tan, and
combined). The total number of possible
points for each of the alternate forms (blue,
tan) is 57, and 99 for the combined form.
Like the WRAT-R, it has good
psychometric properties (Wilkinson, 1993).
Reliability, as measured by a coefficient
Alpha, ranges from .85 to .95 over the 3
forms; test-retest reliability is .91 to .98.
Correlations for the alternate forms over the
age groups range from .87 to .99, with a
median correlation of .92. The WRAT-III
has three subtests (Reading, Spelling, and
Arithmetic). Correlations between the
WRAT-III and WRAT-R reading tests based
on studies with children are: blue form (.90),
tan form (.95), and combined form (.94).
Procedure
Participants were randomly assigned to
two conditions to control for possible order
effects. Participants in one condition were
tested on the English version of the MCMIIII during the first interview and on the
Portuguese version of the MCMI-III after an
interval of 6-14 days, on the second
interview. Participants in the other condition
took the English and Portuguese versions of
the MCMI-III in an inverse order.
Participants in both conditions took the
Reading subtest of the WRAT-III (tan form)
during the second interview. The Reading
subtest of the WRAT-III was used for
subject screening and was administered only
after the subjects had completed the two
versions of the MCMI-III to prevent subjects
who did not qualify for the study from
feeling inadequate about their knowledge of
English.
Data collection took place in different
community locations (homes, churches, or
business sites) to accommodate the subjects’
preferences. It was considered the
researchers’
responsibility
(or other
qualified test administrator selected by the
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researchers), however, to ensure that testing
conditions
were
optimal
before
administering the tests.
Results
We found an average item-by-item
agreement of 90.5% (ranging from 44.4% to
100% agreement). Of the 175 items, 78
achieved 100% agreement, while only 2
items failed to achieve at least a 60%
agreement rate (item 88 with 44.4% and
item 32 with 55.6%). Agreement rates for all
items are presented on Table 1.
Test-retest correlations for BR scores
for all scales were also calculated and are
presented on Table 2 along with first, second
& difference means and standard deviations
and Cohen's d statistic. The median
correlation between versions was .83 (range
= .07 to .96). The d values ranged from 0 to
.6 (Median=.3).
Discussion
The present paper outlined the
methodology used for the translation of the
MCMI-III into Brazilian-Portuguese and
presented the results of the bilingual retest
study. The results are encouraging and may
suggest consistent measurement across
cultures and linguistic equivalency between
the original and the translated instrument.
We are aware, however, that a linguistically
equivalent translation does not necessarily
indicate that both versions are comparable in
all aspects that are important to ensure
appropriate clinical and research use.
Further studies to evaluate the psychometric
properties of the translated instrument and
its validity for use with Brazilians are now
being conducted by our research team and
represent the preliminary steps we have
taken to provide method for future crosscultural studies of personality using the
translated Millon.
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Table 1
Item by Item Agreement Rates Between Testings

Pct.

Pct.

Pct.

Pct.

Pct.

Pct.

Pct.

Item

Agree

Item

Agree

Item

Agree

Item

Agree

Item

Agree

Item

Agree

Item

Agree

001

100.0

026

88.9

051

77.8

076

88.9

101

77.8

126

88.9

151

88.9

002

77.8

027

77.8

052

100.0

077

100.0

102

100.0

127

66.7

152

100.0

003

100.0

028

88.9

053

66.7

078

100.0

103

100.0

128

100.0

153

88.9

004

100.0

029

100.0

054

88.9

079

66.7

104

77.8

129

100.0

154

100.0

005

100.0

030

100.0

055

88.9

080

88.9

105

66.7

130

88.9

155

88.9

006

88.9

031

100.0

056

88.9

081

100.0

106

77.8

131

88.9

156

100.0

007

66.7

032

55.6

057

66.7

082

88.9

107

100.0

132

100.0

157

100.0

008

100.0

033

88.9

058

88.9

083

77.8

108

88.9

133

88.9

158

100.0

009

88.9

034

88.9

059

66.7

084

77.8

109

100.0

134

88.9

159

100.0

010

100.0

035

77.8

060

88.9

085

88.9

110

100.0

135

66.7

160

100.0

011

100.0

036

88.9

061

88.9

086

100.0

111

100.0

136

88.9

161

88.9

012

100.0

037

100.0

062

88.9

087

100.0

112

100.0

137

66.7

162

88.9

013

100.0

038

100.0

063

88.9

088

44.4

113

100.0

138

88.9

163

100.0

014

88.9

039

100.0

064

100.0

089

100.0

114

100.0

139

100.0

164

100.0

015

100.0

040

77.8

065

100.0

090

88.9

115

88.9

140

88.9

165

88.9

016

77.8

041

77.8

066

100.0

091

100.0

116

77.8

141

100.0

166

77.8

017

100.0

042

100.0

067

100.0

092

88.9

117

88.9

142

88.9

167

77.8

018

100.0

043

88.9

068

88.9

093

77.8

118

100.0

143

100.0

168

100.0

019

88.9

044

100.0

069

100.0

094

88.9

119

100.0

144

88.9

169

100.0

020

88.9

045

66.7

070

88.9

095

100.0

120

100.0

145

88.9

170

66.7

021

100.0

046

100.0

071

88.9

096

77.8

121

88.9

146

100.0

171

100.0

022

88.9

047

77.8

072

88.9

097

88.9

122

88.9

147

88.9

172

66.7

023

88.9

048

88.9

073

100.0

098

88.9

123

100.0

148

77.8

173

100.0

024

100.0

049

88.9

074

100.0

099

77.8

124

88.9

149

100.0

174

100.0

025

100.0

050

66.7

075

88.9

100

100.0

125

100.0

150

88.9

175

100.0
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Table 2
First vs. Second Testing Statistics
------------------------------------------------------------------------------------------------------------------------------------------1st Test
2nd Test
Difference
---------------------------Scale
Mean
SD
Mean
SD
r
Mean
SD
d
------------------------------------------------------------------------------------------------------------------------------------------1 Schizoid
52.9 18.8
53.7 18.3
.65
-0.8 15.5
-0.0
2A Avoidant
24.1 20.5
38.0 31.5
.90**
-13.9 15.7
-0.5
2B Depressive
24.4 26.5
33.1 35.3
.79*
-8.7 21.5
-0.3
3 Dependent
32.6 30.5
40.2 30.0
.75*
-7.7 21.2
-0.3
4 Histrionic
62.3 13.1
59.8 18.3
.78*
2.6 11.5
0.2
5 Narcissistic
69.8 14.4
65.8 16.7
.93**
4.0
6.2
0.3
6A Antisocial
41.8 27.9
48.6 20.6
.55
-6.8 23.7
-0.3
6B Aggressive/Sadistic 40.3 25.4
46.0 19.7
.83**
-5.7 14.3
-0.2
7 Compulsive
64.2 16.5
58.2 10.4
.79*
6.0 10.5
0.4
8A Passive-Aggressive
28.2 16.8
39.2 21.5
.94**
-11.0
8.0
-0.6
8B Self-Defeating
18.6 21.8
30.3 33.3
.92**
-11.8 15.6
-0.4
S Schizotypal
21.4 27.2
29.2 34.8
.96**
-7.8 11.7
-0.2
C Borderline
17.1 19.7
28.3 23.3
.68*
-11.2 17.6
-0.5
P Paranoid
26.0 28.9
23.3 26.3
.93**
2.7 10.5
0.1
A Anxiety
24.1 32.9
35.9 41.2
.86**
-11.8 21.1
-0.3
H Somatoform
16.9 26.9
17.7 28.4
.85**
-0.8 15.2
-0.0
N Bipolar: Manic
30.0 31.3
30.7 34.6
.94**
-0.7 11.4
-0.0
D Dysthymia
8.9 20.3
18.7 25.2 -.07
-9.8 33.5
-0.4
B Alcohol Dependence
49.6 19.0
53.7 18.3
.86**
-4.1
9.8
-0.2
T Drug Dependence
40.1 23.5
47.6 23.6
.57
-7.4 21.8
-0.3
R PTSD
8.3 10.9
18.3 23.5
.76*
-10.0 16.8
-0.5
SS Thought Disorder
16.9 19.0
17.8 26.5
.89**
-0.9 12.7
-0.0
CC Major Depression
9.8 20.0
18.2 28.1
.76*
-8.4 18.2
-0.3
PP Delusional Disorder 19.4 26.6
27.9 33.1
.85**
-8.4 17.3
-0.3
Y Desirability
77.8 14.2
70.3 10.8
.76*
7.4
9.3
0.6
Z Debasement
22.7 22.0
23.1 28.3
.61
-0.4 23.0
-0.0
X Disclosure
37.8 20.3
43.9 19.1
.92**
-6.1
7.7
-0.3
-----------------------------------------------------------------------------------------------------------------------------------------** p<.01 *p<.05
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Fort Lauderdale, Florida, USA
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São José do Rio Preto, São Paulo, Brazil
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A Brazilian-Portuguese version of the MCMI-III was developed to be
used in future studies that will examine cross-cultural aspects of
personality and psychopathology in Brazil and the United States. This
paper presents the methodology used to evaluate the translation
methodology for this endeavor (with its statistical results) and testretest reliability of the translated instrument. For evaluation of the
translation phase, using 9 bilingual participants, we found item-by-item
agreement rates ranged from 44% to 100% (Median=90.4%) between
English and Brazilian-Portuguese versions. The median correlation
across the 27 scales was .83 (range = .07 to .96). For the test-retest
phase, using 222 Brazilian college students, the median raw score
correlation between first and second testing across the 27 scales was
.82 (range = .48 to .86). These results are seen as encouraging and
suggest consistency of measurement across time.

The Millon Clinical Multiaxial Inventory
(MCMI) is currently one of the most popular
instruments used for the assessment of adult
psychopathology in the United States (Choca
& Van Denburg, 1997). It has inspired a
growing number of studies since its first
publication in 1977 and now, in its third
version, occupies a central place in many
clinical settings (Craig, 1997). Several
translations and adaptations of the Millon
Inventories to other languages have been
reported in the literature and are currently
being used in many other countries (e.g.
Sloore & Derksen, 1997; Mortensen &
Simonsen, 1990; Luteijn, 1990).
Because of its solid theoretical
foundation, the MCMI seems particularly
appropriate for cross-cultural applications
(Escovar, 1997), allowing for the assessment

of personality disorders and clinical
syndromes at a basic, theoretical level.
Moreover, the instrument’s consonance with
the DSM-IV and ICD-10 facilitates the
interpretation and reporting of results
according to the current psychiatric nosology
used in many countries (Millon & Millon,
1997).
Due
to
the
demand
for
psychological instruments that can be
appropriately used with Portuguese speaking
individuals of Brazilian heritage, we
conducted a translation of the MCMI-III into
Brazilian-Portuguese. Only a small number
of instruments are now available for clinical
and research purposes with a Brazilian
population and a good part of these
instruments are based on projective
diagnostic approaches. There is a need for
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self-report measures in Brazilian-Portuguese
that are reliable, easy to use in a variety of
clinical settings, and up-to-date with the
most current theories of personality and
psychopathology.
The current literature provides several
guidelines for the translation and adaptation
of psychological instruments for crosscultural use (see Van de Vijver & Hambleton,
1996, for a comprehensive description of
potential sources of bias and recommended
practices). The translation/back translation
procedure is considered standard by most test
translators and is used to evaluate whether
original item content is preserved or changed
in the translated version. In this procedure, the
translated items are translated back into the
source language and then compared with the
original version of the instrument to check for
content discrepancies. Although this method
seems to be a common procedure among test
translators (e.g. Sloore & Derksen 1997;
Saito, Nomura, Noguchi & Tezuka, 1996), the
literature advises that it should be used with
caution. According to Geisinger (1994),
research has found that test translators, when
knowing that their work will be subject to
back translation, tend to use wording that
ensures a good match between back
translation and original version, rather than
one that accurately reproduces the original
content of the items. Moreover, readability
and fluency of the text tend to be neglected
when back translation procedures are
employed (Van de Vijver & Hambleton,
1996). Other authorities in the field have
concluded, however, that back translation is a
valuable tool despite its limitations and should
be employed by test translators (Butcher,
1996).
As an alternative technique to back
translation, the use of revisers has been
suggested by Geisinger (1994). He
recommended having a group of individuals
carefully review all translated items, make
comments about the quality of the translation,
and discuss with test translators alternative
wording for problem-items. This review
process is also expected to minimize the

potential for translation bias as well as to
enhance the quality of the final product.
Another recommended practice is the use
of a committee approach to translation
(Butcher, 1998; Sloore & Derksen 1997; Saito
et al, 1996; Butcher, 1996). Rather than
having only one person translate the
instrument, the literature suggests having
members of a translation team make the
translation of all items independently and later
integrate their work into one version on the
basis of discussion. The committee members
should be not only fluent in both languages
but also knowledgeable about both cultures
and the constructs being measured (Geisinger,
1994).
Furthermore, in order to evaluate the
linguistic accuracy of a translated instrument,
a pilot study using bilingual individuals
should be carried out (Butcher, 1998; Sloore
& Derksen, 1997; Butcher, 1996; Saito et al.,
1996). In this method, both versions are
administered to a sample of bilingual subjects
to detect problems with particular items and
evaluate the reliability of the instrument
across versions. Frequent discrepancies
between same items are expected to indicate
possible translation problems and would
suggest the need for further refinement of the
translated item. Genuine cultural differences
that may account for these discrepancies
should be also investigated (Butcher, 1996).
Finally, the stability of the translated
instrument should be tested in the target
culture with a test-retest design (Paunonen &
Ashton, 1998). The correlation coefficients
obtained are expected to approximate the testretest reliability coefficients reported in the
literature for the original version of the
instrument.
The purpose of the present paper is to
describe the methodology used for the
translation of the MCMI-III into BrazilianPortuguese and to present the preliminary
psychometric results obtained with a sample
of Brazilian college students in Rio de Janeiro
and Sao Paulo (Brazil). As noted above,
correlations are expected to approximate the
test-retest reliability of the original MCMI-III
reported in the manual (Millon, 1994). Further
studies will be required to evaluate the
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validity of the new instrument for use with a
Brazilian population. Validity-threatening
factors related to the construct being
measured (construct bias) and to instrument
administration (method bias) should be
examined in the future to ensure appropriate
clinical and research use (Van de Vijver &
Hambleton, 1996).

between back translated items and their
correspondent items in the original version,
the translation committee and the back
translator worked together to detect the reason
for the problems, generate alternative
formulations, and prepare the version used in
the bilingual retest study.
Bilingual Retest

Method
Translation Procedures
Our research team used a combination
of the translation practices discussed in the
literature (Butcher, 1998; Sloore & Derksen,
1997; Saito et al, 1996; Butcher, 1996; Van
de Vijver & Hambleton, 1996; Geisinger,
1994). The initial translation was conducted
independently by two bilingual Brazilians
(two of the authors) and integrated on the
basis of discussion. The integrated version
was then revised by two bilingual research
assistants with extensive experience in both
cultures who made important comments and
suggestions regarding each item. However,
because the revisers were not familiar with the
content of the MCMI-III, their suggestions were
analyzed by the translation committee who made
the necessary adjustments to the items before
submitting them to the back translation
procedure.

When
working
on
the
items
independently, the translation committee and
the revisers were instructed to keep several
principles in mind: (1) if possible, maintain
the original wording and sentence
construction; (2) if necessary, modify the
wording and/or sentence construction making
changes as minimal as possible; (3) try to use
words and sentences that are easy to
understand; (4) if there is more than one way
an item can be translated, choose the most
simple one; (5) if necessary, use explanatory
words/sentences within parenthesis to clarify
words that have ambiguous meaning.
Back translation was conducted by
another Brazilian research assistant with
extensive experience in both cultures. The
back translated items were latter compared to
the original items by an American research
assistant who had no knowledge of
Portuguese. When discrepancies were found

Participants
Potential subjects were recruited from the
community on the basis of their availability.
They were contacted informally through
schools, churches, and businesses that serve
the Brazilian community in Dade and
Broward Counties (Florida, USA). They were
informally approached by the investigators
and invited to participate in the study by
responding anonymously to the assessment
materials. At this time they received a brief
explanation of the purpose of the study and
were assured of their anonymity.
Criteria for inclusion in this study were:
(1) subject’s willingness to participate; (2)
above 18 years of age; (3) above 8 years of
education; and (4) ability to speak and read
English and Brazilian-Portuguese. Subjects
were excluded from the study if they scored
below the 8th Grade level on the reading
subtest of the Wide Range Achievement Test
- 3rd Ed. (WRAT-III; Wilkinson, 1993).
A total number of twenty-one Brazilian
individuals fluent in Brazilian-Portuguese and
English volunteered for this study. From this
group, ten volunteers failed to appear for the
second interview and two did not meet criteria
for inclusion in the study. The remaining
participants were 5 males and 4 females with
ages ranging from 34 to 58 (Mean = 41.7) and
years of education ranging from 10 to 22
(Mean = 12.7).
Instrumentation
Millon Clinical Multiaxial Inventory III. The MCMI-III (Millon, 1994) is a 175item instrument composed of 11 clinical
personality scales, 3 severe personality
pathology scales, 7 clinical syndrome scales,
3 severe syndrome scales, and 4 modifying
indices scales. Due to the norming of the
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MCMI-III on psychiatric patients, base rates
(BR) are employed rather than standard
scores. A BR score of > 75 on a given scale
indicates that feature is present in the
individual's personality, while a BR score of >
85 indicates that feature is prominent in the
composition of their personality. Strengths of
the MCMI-III include its norming on a
psychiatric population, its brevity, and its ease
of administration. Moreover, the Millon
inventories appeal to many professionals as
they define personality traits using
nomenclature with which clinicians are
accustomed (Choca & Van Denburg, 1997;
McCabe, 1984). According to Millon (1994),
internal consistency (alpha) coefficients
exceed .80 for 20 of the 26 scales. Also, the
median stability coefficient, based on two test
administrations between five and 14 days
apart, was .91. Regarding validity, Millon
reported that correlations between scale BR
scores and collateral instruments (e.g., BDI,
MMPI-2, SCL-90-R) were generally
favorable.
Wide Range Achievement Test - III. The
WRAT-III has one level for ages 5-75. There
are three forms (blue, tan, and combined). The
total number of possible points for each of the
alternate forms (blue, tan) is 57, and 99 for the
combined form. Like the WRAT-R, it has
good psychometric properties (Wilkinson,
1993). Reliability, as measured by a
coefficient Alpha, ranges from .85 to .95 over
the 3 forms; test-retest reliability is .91 to .98.
Correlations for the alternate forms over the
age groups range from .87 to .99, with a
median correlation of .92. The WRAT-III has
three subtests (Reading, Spelling, and
Arithmetic). Correlations between the
WRAT-III and WRAT-R reading tests based
on studies with children are: blue form (.90),
tan form (.95), and combined form (.94).
Procedure
Participants were randomly assigned to
two conditions to control for possible order
effects. Participants in one condition were
tested on the English version of the MCMI-III
during the first interview and on the
Portuguese version of the MCMI-III after an

interval of 6-14 days, on the second interview.
Participants in the other condition took the
English and Portuguese versions of the
MCMI-III in an inverse order.
Participants in both conditions took the
Reading subtest of the WRAT-III (tan form)
during the second interview. The Reading
subtest of the WRAT-III was used for subject
screening and was administered only after the
subjects had completed the two versions of
the MCMI-III to prevent subjects who did not
qualify for the study from feeling inadequate
about their knowledge of English.
Data collection took place in different
community locations (homes, churches, or
business sites) to accommodate the subjects’
preferences. It was considered the
researchers’ responsibility (or other qualified
test administrator selected by the researchers),
however, to ensure that testing conditions
were optimal before administering the tests.
Results
We found an average item-by-item
agreement of 90.5% (ranging from 44.4% to
100% agreement). Of the 175 items, 78
achieved 100% agreement, while only 2 items
failed to achieve at least a 60% agreement rate
(item 88 with 44.4% and item 32 with
55.6%). Test-retest correlations for BR scores
for all scales were also calculated (median
correlation = .83; range = .07 to .96). The d
values ranged from 0 to .6 (Median=.3).
These results were seen as encouraging
and suggestive of consistent measurement
across cultures. Items with lower than 80%
agreement were subsequently revised by the
translation committee who worked together to
detect the reason for the problems and to
generate alternative formulations before
preparing the final version used in the retest
study in Brazil. Because the subjects reported
having difficulty understanding certain items
in the English version during test
administration, their limited comprehension
of English was also considered as a possible
explanation for the low agreement achieved
with particular items.
Test-Retest in Brazil
Participants
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A total of two hundred and thirty
five Brazilian College students residing in
Rio de Janeiro and Sao Paulo (Brazil) were
recruited for this study. They were contacted
during class hours by a member of our
research team and invited to participate by
responding anonymously to the assessment
materials. One point toward the final grade
was offered as an incentive for participation.
The subjects were fully informed
about the procedures involved, the risks and
benefits associated with their participation,
and their right to withdraw from the study at
any time. Confidentiality was assured and
those who agreed to participate were asked to
sign an Informed Consent Form. The criteria
for inclusion in this study were: (1) subject’s
willingness to participate; and (2) above 18
years of age.
Only a subset of the total data (n=45)
was analyzed in time to be included in this
report. The sub-sample consisted of 44 female
and 1 male students with an average of 25.7
years of age (SD=8.3) and 15.5 years
(SD=3.2) of education.
Procedure
Each
participant
was
twice
administered
the
Brazilian-Portuguese
translation of the third edition of the Millon
Clinical Multiaxial Inventory (MCMI3-BP)
during class hours. The interval between the
first and second administrations varied
somewhat but was about two weeks on
average
(Mean=13
days,
SD=2.2).
Information regarding the participants’ past
and current psychiatric history, as well as
substance use and trauma, were also collected
and will be presented in future reports.

Results
Stability coefficients were computed
by calculating the Pearson correlations
between scores produced at the first and
second testings. These are shown in Table 1
for both the raw scores and the base rate (BR)
scores. The median correlation between first
and second testing across the 27 scales was
.82 (range = .41 to .92) for raw scores and .79
(range=.49 to .87) for base rates. These results
are seen as encouraging and suggest
consistency of measurement across time.
Discussion
The present paper outlined the
methodology used for the translation of the
MCMI-III into Brazilian-Portuguese and
presented the preliminary psychometric
results obtained with a sample of Brazilian
college students. These results are
encouraging and suggest that the translated
instrument is reliable and comparable to the
original MCMI-III. Correlations for all but
the substance abuse scales were above .6
and significant at .001 level. Since the
participants in this study were students, it’s
not surprising that there would be some
inconsistency in their responses to items
measuring alcohol and drug dependence.
We are aware, however, that a
psychometrically equivalent translation does
not necessarily indicate that both versions are
comparable in all aspects that are important to
ensure appropriate clinical and research use.
Further studies to evaluate its validity for use
with Brazilians are now being conducted by
our research team and represent the
preliminary steps we have taken to provide
method for future cross-cultural studies of
personality using the translated Millon.
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Table 1
Stability Coefficients for
BP-MCMI-III Raw and BR Scores
Scale
1 Schizoid
2A Avoidant
2B Depressive
3 Dependent
4 Histrionic
5 Narcissistic
6A Antisocial
6B Aggress/Sadistic
7 Compulsive
8A Passive/Aggressive
8B Self-Defeating
S Schizotypal
C Borderline
P Paranoid
A Anxiety
H Somatoform
N Bipolar: Manic
D Dysthymia
B Alcohol Dep
T Drug Dep
R PTSD
SS Thought D/O
CC Major Depression
PP Delusional D/O
Y Desirability
Z Debasement

Raw

BR

.781**
.864**
.925**
.851**
.698**
.733**
.731**
.756**
.829**
.776**
.875**
.804**
.869**
.830**
.705**
.868**
.817**
.781**
.697**
.849**
.819**
.797**
.878**
.789**
.729**
.869**

.791**
.867**
.864**
.833**
.786**
.730**
.765**
.784**
.845**
.747**
.795**
.647**
.864**
.784**
.682**
.819**
.836**
.752**
.576**
.572*
.732**
.803**
.863**
.775**
.713**
.820**
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X Disclosure

.860**

.855**

* p<.01

** p<.001
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APPENDIX C
Informed Consent (English Version)
Validity of the Substance Abuse Scales of the Brazilian-Portuguese MCMI-III
Primary Investigator:
Cristina Magalhães, M.S., L.M.H.C.
251 NE 38th ST #309
Oakland Park, FL 33334
Phone: (954) 568-1106
E-mail: magalhac@nova.edu

Faculty Research Advisors:
Alfred Sellers, Ph.D.
3301 College Avenue
Fort Lauderdale, FL 33314 USA
Phone: (954) 262-5810
E-mail: sellers@nova.edu

Research Associate:
Monica Schaly, M.S., L.M.H.C.
Telephone: 011 55 (021) 3393-2687
E-Mail: billynile@yahoo.com.br

Linda Sobell, Ph.D.
3301 College Avenue
Fort Lauderdale, FL 33314 USA
Phone: (954) 262-5811
E-mail: sobelll@nova.edu

Institutional Review Board:
IRB approval #: CPS07060401X
Date of Approval: 07/15/04
Funding Source: None
Phone Number: (954) 262-5369

John Lewis, Ph.D.
3301 College Avenue
Fort Lauderdale, FL 33314 USA
Phone: (954) 262-5729
E-mail: lewis@nova.edu

I. Description of the Study:
I understand that Cristina Magalhães is a doctoral student at Nova Southeastern University engaged in
research for the purpose of fulfilling a requirement for the Doctor of Psychology Degree. I further
understand that this research seeks to evaluate the validity of the Brazilian-Portuguese version of the Millon
Clinical Multiaxial Inventory-III (MCMI-III) for assessing substance abuse problems in the Brazilian
population.
The MCMI-III is a psychological test that was designed to measure personality traits and clinical
syndromes in individuals with different types of problems, including substance abuse. This test was
originally developed in the English language and has been considered valid for use with people who live in
the United States. The researchers are interested in evaluating whether it can be useful for assessing
substance abuse problems among Brazilians as well.
The MCMI-III is composed of 175 statements and individuals completing the test must indicate whether
they think these statements are true or false for them. Examples of these statements are: “I think I am a very
sociable and outgoing person” and “I often allow others to make important decisions for me.” If I decide to
participate in this study, I will be answering three small questionnaires (10 - 11 questions each) in addition
to the MCMI-III. The purpose of these questionnaires is to gather information about my age, gender,
marital status, educational and occupational level, history of alcohol problems and drug abuse, history of
substance abuse treatment. By matching my MCMI-III answers with the information gathered through the
questionnaires, the researchers will be able to determine whether or not the MCMI-III was helpful in
assessing my substance abuse behavior.
The person administering the MCMI-III and questionnaires will strive to arrange the testing session to
accommodate my schedule. Only one testing session will be required. This session is expected to last
between 30 to 40 minutes. No follow-up interview will be needed
II. Risks and Benefits
I understand that there is no direct benefit to me for agreeing to be in this study. The researchers will not
interpret the overall results of my test and will not be able to provide me with information about my scores.
One possible risk to me is that I may initially feel uncomfortable taking the test because it will require
answering items about my attitudes toward aspects of my life that I may consider private. However, I don’t
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have to identify myself by name on the answer sheets and, therefore, my answers can not be traced back to
me. If I have any concerns about my participation in this study, I can discuss them with the research
associate in charge of data collection, Monica Schaly, whose phone number is listed above.
III. Costs and Payments
Participation in this study is voluntary and involves no costs to me. I understand that I will not receive
payment for my participation.
IV. Confidentiality
All information obtained will be keep strictly confidential unless disclosure is required by Brazilian or
United States law. I understand that I don’t need to identify myself by name on the test answer sheets.
Instead, I will be asked to use a number to help the researchers match my answers on the primary test with
my answers on other testing materials without knowing they belong to me. To further protect my identity,
any publications from this study will be written without identifying information. I understand that the
protection of my identity is regarded as an issue of the utmost importance by the researchers and that my
confidentiality will be safeguarded.
If I am a patient at the Pater-Aldeia Clinic, Santa Casa de Misericórdia Hospital, or Primeira Clinica
Popular do Estado do Rio de Janeiro I authorize Monica Schaly to have access to my medical records at the
Pater-Aldeia Clinic, Santa Casa de Misericórdia Hospital or Primeira Clinica Popular do Estado do Rio de
Janeiro. The purpose of this authorization is to allow the researcher to get information about my diagnosis.
I understand that I can revoke this authorization at any time by providing a signed written statement to
Monica Schaly. Although I will not be able to participate in the study procedures if I decide not to give the
authorization, my treatment at the Pater-Aldeia Clinic, Santa Casa de Misericórdia Hospital, or Primeira
Clinica Popular do Estado do Rio de Janeiro will not be affected in any way by my refusal to authorize the
researcher’s access to my records. If I allow this transfer of information from my medical file, the
researchers will protect the confidentiality of this information as discussed in the Confidentiality section
above.
V. Right to Withdraw
I understand that I may discontinue the testing at any time either during or after the study and have all my
answers destroyed unless prohibited by state or federal law. If any significant new information relating to
the study becomes available which may relate to my willingness to continue to participate, this information
will be provided to me by the investigators.
VI. Voluntary Consent
I have read the preceding consent form, or it has been read to me, and I fully understand the
contents of this document and voluntarily consent to participate. All of my questions concerning the
research have been answered. I hereby agree to participate in this research study. If I have any
questions in the future about this study they will be answered by Monica Schaly or any of the other
researchers. If I am a client at the Pater-Aldeia Clinic, Santa Casa de Misericórdia Hospital, or
Primeira Clinica Popular do Estado do Rio de Janeiro I also voluntarily agree to the release of my
medical diagnosis as described in this document. For questions relating to my rights as a participant
of this study, I can contact the president of the Research Ethics Committee of the Núcleo de Estudos
em Saúde Coletiva do Rio de Janeiro, Dr. Marisa Palácios, at (021) 2598-9278. A copy of this form
has been given to me. This consent ends at the conclusion of this study.
________________________________________________________________________
Participant’s Signature
Date
________________________________________________________________________
Witness Signature
Date
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APPENDIX D
Informed Consent (Portuguese Version)
Validade da escala de abuso de substâncias químicas da versão brasileira do MCMI-III
Pesquisador principal:
Cristina Magalhães
Psicóloga e Mestre em Psicologia Clínica
251 NE 38th ST #309
Oakland Park, FL 33334 EUA
Telefone: (954) 568-1106
E-mail: magalhac@nova.edu

Professores orientadores da pesquisa:
Alfred Sellers, Ph.D.
3301 College Avenue
Fort Lauderdale, FL 33314 EUA
Telefone: (954) 262-5810
E-mail: sellers@nova.edu

Colaborador:
Mônica Schaly
Psicóloga e Mestre em Orientação de Saúde Mental
Telefone: 011 55 (021) 3393-2687
E-Mail: billynile@yahoo.com.br

Linda Sobell, Ph.D.
3301 College Avenue
Fort Lauderdale, FL 33314 EUA
Telefone: (954) 262-5811
E-mail: sobelll@nova.edu

Comitê de Ética da Universidade:
Número do projeto: CPS07060401X
Data de aprovação: 15/07/04
Agência patrocinadora: nenhuma
Telefone: (954) 262-5369

John Lewis, Ph.D.
3301 College Avenue
Fort Lauderdale, FL 33314 EUA
Telefone: (954) 262-5729
E-mail: lewis@nova.edu

I. Descrição do estudo:
Fui informado(a) de que a pesquisadora Cristina Magalhães está conduzindo um estudo científico com o
objetivo de cumprir os requerimentos do seu curso de doutorado em Psicologia Clínica pela Nova
Southeastern University. Também fui informado(a) de que este estudo tem por objetivo avaliar a validade
da versão brasileira do Inventório Clínico e Multiaxial-III (MCMI-III) para o diagnóstico de problemas de
abuso de substâncias químicas na população brasileira.
O MCMI-III é um teste psicológico que foi desenvolvido com o objetivo de facilitar a identificação de
vários distúrbios de personalidade e síndromes clínicas em pessoas com diferentes tipos de problemas,
inclusive abuso de substâncias químicas. Este teste foi originalmente desenvolvido em inglês e é
considerado válido para utilização com pessoas que vivem nos Estados Unidos. Os pesquisadores estão
interessados em avaliar se este teste também pode ser útil no diagnóstico de problemas de abuso de
substâncias químicas em brasileiros.
O MCMI-III é composto de 175 frases (declarações), e as pessoas que participam deste teste devem indicar
se pensam que essas frases se aplicam ou não a elas (se são verdadeiras ou falsas). Exemplos dessas frases
são: “Eu me considero uma pessoa muito sociável e extrovertida” e “Eu costumo deixar que outros tomem
decisões importantes por mim”. Se eu decidir participar deste estudo, estou ciente de que, além do MCMIIII, vou responder a três pequenos questionários (10 a 11 questões). O objetivo destes questionários é
coletar informações sobre a minha idade, sexo, estado civil, ocupação, educação, histórico de problemas
com abuso de substâncias químicas e tratamentos. Comparando as minhas respostas no MCMI-III com as
informações obtidas através destes questionários, os pesquisadores serão capazes de avaliar se o MCMI-III
foi ou não útil para identificar o meu comportamento em termos de uso de substâncias químicas.
A pessoa responsável por administrar o teste fará o possível para que a sessão de testagem seja realizada
segundo a minha conveniência. Somente uma sessão de testagem será necessária, e esta deverá durar de 30
a 40 minutos. Não será necessária nenhuma sessão para entrega de resultados.
II. Riscos e benefícios
Estou ciente de que não serei beneficiado(a) diretamente por participar deste estudo. Os pesquisadores não
irão produzir uma interpretação geral das minhas respostas e, portanto, não poderão me fornecer
informações sobre o meu resultado.
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Se eu participar deste estudo, o único risco que posso correr é o de me sentir um pouco constrangido(a) por
estar respondendo a perguntas sobre aspectos da minha vida que considero privados. Entretanto, sei que
não precisarei me identificar pelo meu nome nas folhas de resposta e, portanto, que minhas respostas não
poderão ser reconhecidas como pertencentes a mim. Se eu tiver qualquer pergunta referente à minha
participação neste estudo, sei que posso contatar a pessoa responsável pela coleta de dados, Monica Schaly,
cujo número telefônico está listado acima.
III. Custos e gratificações
Minha participação neste estudo é voluntária. Eu compreendo que não receberei nenhum incentivo
financeiro pela minha participação.
IV. Confidencialidade
Todas as informações obtidas pelos pesquisadores serão consideradas de caráter confidencial, a menos que
a divulgação das mesmas seja exigida pela legislação brasileira ou norte-americana. Eu compreendo que
não preciso me identificar pelo meu nome nas folhas de resposta, mas sei que serei instruído(a) a usar um
número de identificação para que os pesquisadores possam combinar minhas folhas de resposta sem saber
que pertencem a mim. Para proteger minha identidade, qualquer publicação futura a respeito deste estudo
será feita de modo a que nenhuma informação possa identificar qualquer um dos participantes. Eu
compreendo que a proteção da minha identidade é considerada um assunto de grande importância para os
pesquisadores e que minha confidencialidade será preservada.
Caso eu seja um paciente na Clínica Pater-Aldeia, Santa Casa de Misericórdia do Rio de Janeiro, ou 1ª
Clínica Popular do Estado do Rio de Janeiro, autorizo Mônica Schaly a ter acesso ao meu prontuário
médico da clínica/hospital. O propósito desta autorização é conceder permissão aos pesquisadores para que
possam obter informações sobre o meu diagnóstico. Eu compreendo que posso revogar essa autorização a
qualquer momento, entregando um pedido por escrito à Mônica Schaly. Caso eu decida não autorizar o
acesso dos pesquisadores ao meu prontuário médico, sei que não poderei participar da pesquisa, mas
entendo que o meu tratamento na Clínica Pater-Aldeia, Santa Casa de Misericórdia do Rio de Janeiro, ou 1ª
Clínica Popular do Estado do Rio de Janeiro, não será alterado ou prejudicado de forma alguma. Se eu
permitir o acesso dos pesquisadores ao meu prontuário médico, eles protegerão a confidencialidade dessas
informações conforme discutido no parágrafo acima.
V. Direito de desistência
Eu compreendo que tenho o direito de interromper minha testagem e pedir que todas as minhas respostas
sejam destruídas (durante ou depois de o estudo ter sido concluído), exceto em situações em que tal
procedimento seja proibido pela legislação estadual ou federal. Se alguma informação nova a respeito desse
estudo se tornar disponível e puder ter alguma influência na minha decisão de participar, esta informação
me será fornecida pelos pesquisadores.
VI. Consentimento voluntário
Atesto que li este consentimento de participação (ou me foi lido por outra pessoa), compreendo totalmente o conteúdo deste
documento, e concordo em participar voluntariamente desta pesquisa. Todas as minhas dúvidas referentes a este estudo foram
respondidas. Eu concordo em participar deste estudo. Se no futuro tiver perguntas a respeito deste estudo, sei que serão
respondidas por Mônica Schaly ou qualquer um dos outros pesquisadores. Caso eu seja um paciente da Clínica Pater-Aldeia,
Santa Casa de Misericórdia do Rio de Janeiro, ou 1ª Clínica Popular do Estado do Rio de Janeiro, também voluntariamente
concordo com o acesso dos pesquisadores ao meu diagnóstico médico, conforme descrito neste documento. Para questões
relacionadas aos seus direitos como paciente do estudo de pesquisa, contate a Presidente do Comitê de Ética em Pesquisa do
Núcleo de Estudos em Saúde Coletiva do Rio de Janeiro, Dra. Marisa Palácios, tel: 2598 9278. Recebi uma cópia deste
consentimento de participação. Este consentimento será válido somente até a conclusão deste estudo.

________________________________________________________________________
Assinatura do(a) participante voluntário(a) da pesquisa
Data
________________________________________________________________________
Assinatura da testemunha
Data
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APPENDIX E
The Alcohol Dependence Scale Composition and Item Weighing
for the Original and Translated Versions of the MCMI-III (Millon, 1997).
True Prototypal Items (weigh = 2)
52 I have an alcohol problem that has made
difficulties for me and my family.
77 I have a great deal of trouble trying to control
an impulse to drink to excess.
100 I guess I’m no different from my parents in
becoming somewhat of an alcoholic.
131 Drinking alcohol helps when I’m feeling
down.
152 I have a drinking problem that I’ve tried
unsuccessfully to end.

Eu tenho um problema com bebida alcoólica,
que já gerou dificuldades para mim e minha
família.
Eu tenho bastante dificuldade de controlar um
impulso de beber em excesso.
Eu acho que não sou diferente dos meus pais em
me tornar um pouco alcoólatra.
Tomar bebida alcoólica ajuda quando me sinto
deprimido.
Eu tenho um problema com bebida alcoólica
que já tentei acabar, mas não fui bem sucedido.

True Nonprototypal Items (weigh = 1)
14 Sometimes I can be pretty rough and mean in
my relations with my family.
41 I’ve done a number of stupid things on
impulse that ended up causing me a great
trouble.
64 I don’t know why, but I sometimes say cruel
things just to make others unhappy.
93 There are members of my family who say I’m
selfish and think only of myself.
101 I guess I don’t take many of my family
responsibilities as seriously as I should.
113 I’ve gotten into trouble with the law a couple
of times.
122 I seem to make a mess of good opportunities
that come my way.
139 I’m very good at making up excuses when I
get into trouble.
166 I act quickly much of the time and don’t think
things through as I should.

Ás vezes sou bastante rude e perverso com a
minha família.
Já fiz várias coisas estúpidas sem pensar, que
acabaram me causando grandes problemas.
Não sei porque, mas às vezes eu falo coisas
cruéis só para fazer os outros infelizes.
Alguns membros da minha família dizem que
sou egoísta e que só penso em mim mesmo.
Eu acho que não levo muitas das minhas
responsabilidades familiares tão à sério quanto
deveria.
Eu me envolvi em problemas com a lei algumas
vezes.
Parece que estrago as boas oportunidades que
me surgem.
Eu sou muito bom em inventar desculpas
quando me envolvo em encrencas.
Na maioria das vezes eu ajo impulsivamente e
sem pensar nas consequências como deveria.

False Prototypal Item (weight = 2)
23 Drinking alcohol has never caused me any
real problems in my work.

Bebida alcoólica nunca me causou grandes
problemas no meu trabalho.
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APPENDIX F
The Drug Dependence Scale Composition and Item Weighing
for the Original and Translated Versions of the MCMI-III (Millon, 1997)
True Prototypal Items (weigh = 2)
13 My drug habits have often gotten me into a
good deal of trouble in the past.
39 Taking so-called illegal drugs may be unwise,
but in the past I found I needed them.
66 My habit of abusing drugs has caused me to
miss work in the past.
91 My use of so-called illegal drugs has led to
family arguments.
118 There have been times when I couldn’t get
through the day without some street drugs.
136 I know I’ve spent more money than I should
buying illegal drugs.

Meu uso de drogas já me causou muitos
problemas no passado.
Fazer uso de drogas ilegais pode ser uma
imprudência, mas no passado eu precisei delas.
Meu hábito de abusar de drogas me fez perder
dias de trabalho.
Meu uso de drogas ilegais já causou discussões
de família.
Ja existiram épocas em que eu não conseguia
passar o dia sem usar drogas.
Eu sei que gastei mais dinheiro do que deveria
comprando drogas.

True Nonprototypal Items (weigh = 1)
7 If my family puts pressure on me, I’m likely
to feel angry and resist doing what they want.
21 I like to flirt with members of the opposite
sex.
38 I do what I want without worrying about its
effect on others.
41 I’ve done a number of stupid things on
impulse that ended up causing me great
trouble.
53 Punishment has never stopped me from doing
what I wanted.
101 I guess I don’t take many of my family
responsibilities as seriously as I should.
113 I’ve gotten into trouble with the law a couple
of times.
139 I’m very good at making up excuses when I
get into trouble.

Quando a minha família me pressiona, eu
costumo ficar zangado e procuro não fazer o
que eles querem.
Gosto de flertar (paquerar) com as pessoas do
sexo oposto.
Faço o que quero sem me preocupar como isso
afeta os outros.
Já fiz várias coisas estúpidas sem pensar, que
acabaram me causando grandes problemas.
Nunca deixei de fazer o que eu queria por medo
de ser castigado.
Eu acho que não levo muitas das minhas
responsabilidades familiares tão à sério quanto
deveria.
Eu me envolvi em problemas com a lei algumas
vezes.
Eu sou muito bom em inventar desculpas
quando me envolvo em encrencas.
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APPENDIX G
Diagnostic Questionnaire (English Version)

Past Use of Alcohol Questions
The following statements are about your alcohol use over the past 12 months. Please check YES for those statements
that describe your drinking during the past 12 months, and check NO for those statements that are not true for you.

Yes
1.

In the past 12 months, I often used alcohol in larger amounts or over longer periods of time
than I intended.

2.

In the past 12 months, I often wanted to or tried to cut down or control my alcohol use.

3.

In the past 12 months, I spent a lot of time either (a) using alcohol, (b) in activities trying to
obtain alcohol, or (c) recovering from the effects of my drinking.

4.

In the past 12 months, I gave up or reduced my involvement in important social, occupational,
or recreational activities because of my alcohol use.

5.

In the past 12 months, I continued to use alcohol despite knowing that it likely caused or made
worse psychological or physical problems I had (e.g., continued drinking knowing it was
making my ulcer or depression worse).

6.

In the past 12 months, I found I needed greater amounts of alcohol than I use to in order to feel
intoxicated or to get a desired effect, OR I got much less of an effect by using the same amount
of alcohol as in the past.

7.

In the past 12 months, I experienced withdrawal symptoms when I tried to cut down or stop my
drinking OR I drank alcohol to relieve or avoid withdrawal symptoms. IF YES, PLEASE
DESCRIBE YOUR WITHDRAWAL SYMPTOMS:

No

F F
F F
F F
F F
F F
F F
F F

_________________________________________________
8.

In the past 12 months, my continued alcohol use resulted in my not fulfilling major obligations
at work, school, or home (e.g., repeated absences or poor performances at work or school;
neglecting my children or home).

F F

9.

In the past 12 months, I repeatedly used alcohol in situations that were physically hazardous
(e.g., driving a car or operating machinery).

F F
F F

11. In the past 12 months, I continued to use alcohol despite having persistent or recurrent social or
interpersonal problems caused or made worse by the effects of my drinking (e.g., arguments
with friends or family about my drinking or physical fights).

F F

OFFICE USE
ONLY

10. In the past 12 months, my drinking has resulted in my having recurrent substance-related legal
problems.

If 3 or more YES responses are given for Items 1 through 7, then the criteria for
dependence (303.90) have been satisfied.
If 1 or more YES response(s) are given for Items 8 through 11, then the criteria for abuse
(305.00) have been satisfied.

F F
F F
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Past Use of Drug Questions
The following questions are about your use of the drug __________________over the past 12 months. Please check
YES for those statements that describe your use of ___________________ over the past 12 months, and check NO for
those statements that are not true for you.

Yes
1.

In the past 12 months, I often used (drug listed above) in larger amounts or over longer
periods of time than I intended.

2.

In the past 12 months, I often wanted to or tried to cut down or control my use of (drug listed
above).

3.

In the past 12 months, I spent a lot of time either (a) using (drug listed above), (b) in activities
trying to obtain (drug listed above), or (c) recovering from the effects of my use of (drug
listed above).

4.

In the past 12 months, I gave up or reduced my involvement in important social, occupational,
or recreational activities because of my use of (drug listed above).

5.

In the past 12 months, I continued to use (drug listed above) despite knowing that it likely
caused or made worse psychological or physical problems I had (e.g., continued drug knowing
it was making my hepatitis or depression worse.

6.

In the past 12 months, I found that I needed greater amounts of (drug listed above) than I use
to in order to feel intoxicated or to get a desired effect OR that I got much less effect by using
the same amount of (the drug listed above) as in the past.

7.

In the past 12 months, I experienced withdrawal symptoms when I tried to cut down or stop my
use of use of (drug listed above) OR I took (drug listed above) to relieve or avoid withdrawal
symptoms. IF YES, PLEASE DESCRIBE YOUR WITHDRAWAL SYMPTOMS:

No

F F
F F
F F
F F
F F
F F
F F

_________________________________________________
_________________________________________________
_________________________________________________
___
8.

In the past 12 months, my continued use of (drug listed above) resulted in my not fulfilling
major obligations at work, school, or home (e.g., repeated absences or poor performances at
work or school; neglecting my children or home).

F F

9.

In the past 12 months, I repeatedly used (drug listed above) in situations that were physically
hazardous (e.g., driving a car or operating machinery).

F F
F F

11. In the past 12 months, I continued to use (drug listed above) despite having persistent or
recurrent social or interpersonal problems caused or made worse by the effects of my use of
(e.g., arguments with friends or family about my drug use or physical fights).

F F

OFFICE USE
ONLY

10. In the past 12 months, my use of (drug listed above) has resulted in my having recurrent
substance-related legal problems.

If 3 or more YES responses are given for Items 1 through 7, then the criteria for dependence
have been satisfied.
If 1 or more YES response(s) is given for Items 8 through 11, then the criteria for abuse
have been satisfied.

F F
F F
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APPENDIX H
Diagnostic Questionnaire (Portuguese Version)

Perguntas Relacionadas ao Consumo de Bebidas Alcoólicas
As perguntas a seguir referem-se ao seu consumo de bebidas alcoólicas nos últimos 12 meses. Favor responder SIM
para os itens que descrevem corretamente o seu consumo de álcool nos últimos 12 meses e NÃO para os itens que não
se aplicam a você.

SIM NÃO
1.

Nos últimos 12 meses, tomei muitas vezes bebidas alcoólicas em quantidades maiores do que
tinha planejado ou durante períodos mais longos do que tinha planejado.

F F

2.

Nos últimos 12 meses, quis muitas vezes parar de beber ou tentei diminuir ou controlar o meu
consumo de bebidas alcoólicas.

F F

3.

Nos últimos 12 meses, perdi muito tempo usando bebidas alcoólicas, em atividades que tinham
o propósito de obter bebidas alcoólicas, ou me recuperando dos efeitos do uso de bebidas
alcoólicas.

F F

4.

Nos últimos 12 meses, por causa da bebida, parei ou reduzi o meu envolvimento em atividades
importantes de caráter social, de trabalho, ou lazer.

5.

Nos últimos 12 meses, continuei consumindo bebidas alcoólicas apesar de saber que o álcool
estava causando ou agravando alguns dos meus problemas físicos ou psicológicos (por
exemplo, continuei a beber mesmo sabendo que a bebida estava piorando a minha úlcera ou
depressão).

6.

Nos últimos 12 meses, precisei aumentar a quantidade de bebidas alcoólicas que consumia para
poder me sentir intoxicado ou para conseguir o efeito desejado. OU, passei a sentir um efeito
bem menor do que eu costumava sentir no passado bebendo a mesma quantidade de álcool.

7.

Nos últimos 12 meses, senti sintomas de abstinência quando tentei diminuir ou parar de
beber OU consumi bebidas alcoólicas para aliviar ou evitar sintomas de abstinência. SE A
SUA RESPOSTA FOR SIM, FAVOR DESCREVER ABAIXO SEUS SINTOMAS DE
ABSTINÊNCIA:

F F
F F
F F
F F

_______________________________________________
8. Nos últimos 12 meses, não consegui desempenhar bem minhas funções no trabalho, escola ou
casa por causa do meu uso contínuo de álcool (por exemplo, perdi muitos dias de trabalho ou
escola; ou deixei de dar atenção aos meus filhos ou negligenciei a minha casa).

F F

9.

F F

Nos últimos 12 meses, muitas vezes eu bebi em situações que eram perigosas e poderiam me
causar danos físicos (por exemplo, dirigindo um carro ou manipulando máquinas).

10. Nos últimos 12 meses, tive vários problemas com a lei decorrentes do meu consumo de álcool.

OFFICE USE
ONLY

11. Nos últimos 12 meses, continuei a beber embora tenha enfrentado problemas de relacionamento
ou problemas sociais constantes ou recorrentes, os quais foram causados ou agravados pelos
efeitos da bebida (por exemplo, discussões com amigos ou familiares sobre o meu consumo de
álcool ou brigas).
If 3 or more YES responses are given for Items 1 through 7, then the criteria for dependence
have been satisfied.
If 1 or more YES response(s) is given for Items 8 through 11, then the criteria for abuse
have been satisfied.

F F
F F
F F
F F
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Perguntas Relacionadas ao Uso de Drogas
As perguntas a seguir referem-se ao seu uso da droga ________________________ nos últimos 12 meses. Favor
responder SIM para os itens que descrevem corretamente o seu uso de ________________________ nos últimos 12
meses e NÃO para os itens que não se aplicam a você.

SIM

NÃO

1.

Nos últimos 12 meses, usei muitas vezes a droga acima citada em quantidades maiores do que
tinha planejado ou durante períodos mais longos do que tinha planejado.

F F

2.

Nos últimos 12 meses, quis muitas vezes parar de usar ou tentei diminuir ou controlar o meu
uso da droga acima citada.

F F

3.

Nos últimos 12 meses, perdi muito tempo usando a droga acima citada, em atividades que
tinham o propósito de obter a droga, ou me recuperando dos efeitos do uso da droga.

4.

Nos últimos 12 meses, por causa da droga acima citada, parei ou reduzi o meu envolvimento
em atividades importantes de caráter social, de trabalho, ou lazer.

5.

Nos últimos 12 meses, continuei o uso da droga acima citada apesar de saber que estava
causando ou agravando alguns dos meus problemas físicos ou psicológicos (por exemplo,
continuei a usar a droga mesmo sabendo que estava piorando a minha hepatite ou depressão).

6.

Nos últimos 12 meses, precisei aumentar a quantidade da droga acima citada que usava para
poder me sentir intoxicado ou para conseguir o efeito desejado. OU, passei a sentir um efeito
bem menor do que eu costumava sentir no passado usando a mesma quantidade da droga.

7.

Nos últimos 12 meses, senti sintomas de abstinência quando tentei diminuir ou parar de
usar a droga acima citada OU usei a droga para aliviar ou evitar sintomas de abstinência.
SE A SUA RESPOSTA FOR SIM, FAVOR DESCREVER ABAIXO SEUS SINTOMAS
DE ABSTINÊNCIA:

F F
F F
F F
F F
F F

_______________________________________________
_______________________________________________
Nos últimos 12 meses, não consegui desempenhar bem minhas funções no trabalho, escola ou
casa por causa do meu uso contínuo da droga acima citada (por exemplo, perdi muitos dias de
trabalho ou escola; ou deixei de dar atenção aos meus filhos ou negligenciei a minha casa).

F F

9.

Nos últimos 12 meses, muitas vezes eu usei a droga acima citada em situações que eram
perigosas e poderiam me causar danos físicos (por exemplo, dirigindo um carro ou
manipulando máquinas).

F F

10. Nos últimos 12 meses, tive vários problemas com a lei decorrentes do meu uso da droga acima
citada.

F F

11. Nos últimos 12 meses, continuei a usar a droga acima citada embora tenha enfrentado
problemas de relacionamento ou problemas sociais constantes ou recorrentes, os quais foram
causados ou agravados pelos efeitos da droga (por exemplo, discussões com amigos ou
familiares sobre o meu uso da droga ou brigas).

F F

OFFICE USE
ONLY

8.

If 3 or more YES responses are given for Items 1 through 7, then the criteria for dependence
have been satisfied.
If 1 or more YES response(s) is given for Items 8 through 11, then the criteria for abuse
have been satisfied.

F F
F F
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APPENDIX I
English Version of the Alcohol Use Disorders Identification Testa
1. How often do you have a drink containing
alcohol?

(0) Never [Skip to Qs 9-10]
(1) Monthly or less
(2) 2 to 4 times a month
(3) 2 to 3 times a week
(4) 4 or more times a week
2. How many drinks containing alcohol do you
have on a typical day when you are drinking?
(0) 1 or 2
(1) 3 or 4
(2) 5 or 6
(3) 7, 8, or 9
(4) 10 or more
3. How often do you have six or more drinks on
one occasion?

(0) Never
(1) Less than monthly
(2) Monthly
(3) Weekly
(4) Daily or almost daily
4. How often during the last year have you found
that you were not able to stop drinking once
you had started?
(0) Never
(1) Less than monthly
(2) Monthly
(3) Weekly
(4) Daily or almost daily
5. How often during the last year have you failed
to do what was normally expected from you
because of drinking?
(0) Never
(1) Less than monthly
(2) Monthly
(3) Weekly
(4) Daily or almost daily
a

Babor, Higgins-Biddle, Saunders, & Monteiro, 2001.

6. How often during the last year have you needed a
first drink in the morning to get yourself going
after a heavy drinking session?
(0) Never
(1) Less than monthly
(2) Monthly
(3) Weekly
(4) Daily or almost daily
7. How often during the last year have you had a
feeling of guilt or remorse after drinking?
(0) Never
(1) Less than monthly
(2) Monthly
(3) Weekly
(4) Daily or almost daily
8. How often during the last year have you been
unable to remember what happened the night
before because you had been drinking?
(0) Never
(1) Less than monthly
(2) Monthly
(3) Weekly
(4) Daily or almost daily
9. Have you or someone else been injured as a
result of your drinking?

(0) No
(2) Yes, but not in the last year
(4) Yes, during the last year

10. Has a relative or friend or a doctor or another
health worker been concerned about your
drinking or suggested you cut down?
(0) No
(2) Yes, but not in the last year
(4) Yes, during the last year
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APPENDIX J
Portuguese Version of the Alcohol Use Disorders Identification Test
1. Com que freqüência você consome bebidas
alcoólicas?

(0) Nunca [vá para as questões 9-10]
(1) Mensalmente ou menos
(2) De 2 a 4 vezes por mês
(3) De 2 a 3 vezes por semana
(4) 4 ou mais vezes por semana

6. Quantas vezes ao longo dos últimos 12 meses
você precisou beber pela manhã para poder se
sentir bem ao longo do dia após ter bebido
bastante no dia anterior?
(0) Nunca
(1) Menos do que uma vez ao mês
(2) Mensalmente
(3) Semanalmente
(4) Todos ou quase todos os dias

2. Quantas doses alcoólicas você consome 7. Quantas vezes ao longo dos últimos 12 meses
tipicamente ao beber?
você se sentiu culpado ou com remorso depois
de ter bebido?
(0) 0 ou 1
(1) 2 ou 3
(2) 4 ou 5
(3) 6 ou 7
(4) 8 ou mais
3. Com que freqüência você consome cinco ou
mais doses de uma vez?

(0) Nunca
(1) Menos do que uma vez ao mês
(2) Mensalmente
(3) Semanalmente
(4) Todos ou quase todas os dias

(0) Nunca
(1) Menos do que uma vez ao mês
(2) Mensalmente
(3) Semanalmente
(4) Todos ou quase todos os dias
8. Quantas vezes ao longo dos últimos 12 meses
você foi incapaz de lembrar o que aconteceu
devido à bebida?
(0) Nunca
(1) Menos do que uma vez ao mês
(2) Mensalmente
(3) Semanalmente
(4) Todos ou quase todos os dias

4. Quantas vezes ao longo dos últimos 12 meses 9. Você já causou ferimentos ou prejuízos a você
você achou que não conseguiria parar de
mesmo ou a outra pessoa após ter bebido?
beber uma vez tendo começado?
(0) Nunca
(1) Menos do que uma vez ao mês
(2) Mensalmente
(3) Semanalmente
(4) Todos ou quase todos os dias

(0) Não
(2) Sim, mas não nos últimos 12 meses
(4) Sim, nos últimos 12 meses

5. Quantas vezes ao longo dos últimos 12
10. Algum parente, amigo ou médico já se
meses você, por causa do álcool, não
preocupou com o fato de você beber ou sugeriu
conseguiu fazer o que era esperado de você?
que você parasse?
(0) Nunca
(1) Menos do que uma vez ao mês
(2) Mensalmente
(3) Semanalmente
(4) Todos ou quase todos os dias

(0) Não
(2) Sim, mas não nos últimos 12 meses
(4) Sim, nos últimos 12 meses
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APPENDIX K
Demographic Questionnaire
No de Identificação:

Idade:

Identification Number

Age

Local de Coleta de Dados:

Sexo:

Data Collection Site

Gender

(1) Santa Casa
(2) Pater-Aldeia

(3) Igreja Betânia

(5) Clinica Popular

(1) masculino

(4) Igreja Congregacional

female

Estado Civil:

Ocupação:

Escolaridade:

Marital Status

Type of Work

Educational Level

(1) solteiro/solteira

(1) escritório

single

Primário:

office

(2) casado/casada

Ginásio:

factory

(4) desempregado

separated – divorced

unemployed

complete

(5) incompleto

Universitário:

complete

(7) incompleto

(8) completo

incomplete

complete

Pós-Universitário (9) incompleto

other

(6) completo

incomplete

college

(5) outro _____________

(4) completo

incomplete

high school

(4) separado ou divorciado

complete

(3) incompleto

2º grau:

professional

widowed

(2) completo

incomplete

middle school

(3) profissional liberal

(3) viúvo/viúva

(1) incompleto

elementary school

(2) fábrica

married

(2) feminino

male

graduate

(10) completo

incomplete

complete

Principal Razão para o Tratamento:
Primary Reason for Treatment

(1) problemas com uso de álcool
alcohol problems

(2) problemas com uso de drogas

(3) problemas com uso de álcool e drogas

drug problems

alcohol and drug problems

Tratamentos Anteriores:

Religião:

Treatment History

Religion

A. Quantas vezes você já recebeu tratamento para dependência ou abuso de alcool?
How many times in the past you received treatment for alcohol abuse/dependence?

(1) nenhuma vez
never

(2) 1 - 2 vezes
1 – 2 times

(3) 3 – 4 vezes

(4) 5 ou mais vezes

3 – 4 times

5 or more times

B. Quantas vezes você já recebeu tratamento para dependência ou abuso de drogas?
How many times in the past you received treatment for drug abuse/dependence?

(1) nenhuma vez
never

(2) 1 - 2 vezes
1 – 2 times

(3) 3 – 4 vezes

(4) 5 ou mais vezes

3 – 4 times

5 or more times

História de Uso:
History of Substance Use

A.

Com que idade você começou a tomar bebidas alcoólicas? ____________
At what age did you start drinking alcohol?

B.

Com que idade você fez uso de drogas pela primeira vez? _____________
At what age did you use illegal drugs for the first time?

(1) Nenhuma
none
(2) Protestante
Protestant
(3) Católica
Catholic
(4) Espírita
Spiritism
(5) Afro-Brasileira
Afro-Brazilian
(6) Outra
other

_________________
_________________
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APPENDIX L
Instructions for Data Collection

INTRODUCTION
This document provides instructions regarding the recruitment of participants and the
administration of the assessment instruments for the study titled “the BrazilianPortuguese MCMI-III: Diagnostic Validity of the Substance Dependence Scales.” It is
important that any one involved in the data collection phase of this project, read,
understand, and abide by all procedures described in this document. The reliability of the
results obtained at the end of this study directly depends on how well and uniform the
data will be produced. In case this manual does not answer all your questions regarding
the recruitment of the participants and the administration of the assessment procedures,
please contact the principal investigator, Cristina Magalhaes, either by e-mail
(magalhac@nova.edu) or by phone (954-568-1106 or 954-937-0240).
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I.

Purpose of the Study

This study seeks to evaluate the validity of the Brazilian-Portuguese version of the Millon
Clinical Multiaxial Inventory-III (MCMI-III) for assessing substance abuse problems in
the Brazilian population. The MCMI-III is a psychological test that was designed to
measure personality traits and clinical syndromes in individuals with different types of
problems, including substance abuse. This test was originally developed in the English
language and has been considered valid for use with people who live in the United States.
The researchers are interested in evaluating whether it can be useful for assessing
substance abuse problems among Brazilians as well.
The MCMI-III is composed of 175 statements and individuals completing the test must
indicate whether they think these statements are true or false for them. Examples of these
statements are: “I think I am a very sociable and outgoing person” and “I often allow
others to make important decisions for me.” If they decide to participate in this study,
they will be answering three small questionnaires (10 - 11 questions each) in addition to
the MCMI-III. The purpose of these questionnaires is to gather information about their
age, gender, marital status, educational and occupational level, history of alcohol
problems and drug abuse, history of substance abuse treatment. By matching the
participants’ MCMI-III answers with the information gathered through the
questionnaires, the researchers will be able to determine whether or not the MCMI-III
was helpful in assessing their substance abuse behavior.
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II.

Assessment Measures

A.

Description
1) MCMI-III. The MCMI-III is a psychological test that was designed to measure
personality traits and clinical syndromes in individuals with different types of
problem. It has a total of 27 subscales: (a) 3 for estimating the individual’s testtaking attitude, (b) 14 for measuring different personality styles, and (c) 10 for
assessing the presence of clinical syndromes, including anxiety, depression,
psychotic disorders, posttraumatic stress, and substance abuse/dependence.
The MCMI-III is composed of 175 statements and individuals completing the test
must indicate whether they think these statements are true or false for them.
Examples of these statements are: “I think I am a very sociable and outgoing
person” and “I often allow others to make important decisions for me.” Due to the
fact that the Portuguese language has gender-specific words, the development of
gender-specific forms was deemed appropriate for use in the present study
(masculine and feminine forms).
2) AUDIT. The AUDIT is a screening instrument specifically used for the
detection of mild to severe drinking problems. This instrument is a questionnaire
containing 10 items related to alcohol consumption patterns, in which respondents
are asked to select their answers from specified categories.
3) Diagnostic Questionnaire. This instrument is a symptom checklist for
diagnosing substance abuse and dependence according to the DSM-IV-TR. This
instrument contains 11 yes-no questions, each corresponding to a specific
diagnostic criterion listed under the DSM-IV-TR diagnostic code. Separate forms
for alcohol and drug abuse/dependence are available.
4) Demographic Questionnaire. This questionnaire will gather general
information about the subjects’ age, gender, educational level, history of alcohol
problems and drug abuse, history of substance abuse treatment, and admitting
ICD-10 diagnosis (for participants receiving treatment at the Pater-Aldeia Clinic
or Santa Casa de Misericordia Hospital).

All participants (clinical and non-clinical) will be administered all instruments and are
expected to complete the assessment packet approximately within 30 to 40 minutes. They
should be administered the assessment materials in counterbalanced order to control for
possible order effects. Approximately half of the total sample should complete the
assessment measures in the following order: demographic questionnaire, BP-MCMI-III,
AUDIT, and diagnostic questionnaire (assessment packet with green face-sheet and odd
identification number). The other half should complete the assessment measures in the
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following order: demographic questionnaire, AUDIT, diagnostic questionnaire, and BPMCMI-III (assessment packet with pink face-sheet and even identification number).
B.

Self-Report Measures

All assessment instruments used in this study rely on respondent self-report. They were
developed for use with adults (18 years-old and above) who know how to read and write.
Preferably, subjects should have a minimum of 8th grade education.
Self-report measures are most reliable when respondents have at least average
intelligence, have no difficulty understanding the items, know themselves well enough to
answer the questions accurately, and are willing to share what they know openly and
nondefensively (Choca and Van Denburg, 1997). If during administration the examiner
has reason to suspect that a particular subject is answering the questions in a way that
would render the results unreliable, the answer sheets produced by this subject should be
marked with a question mark sign (?) at the top left corner, for later identification of
potentially unreliable protocols. The examiner should also write a brief explanation of
why he/she believes the protocol may be invalid.
Some respondents may find the MCMI-III questions strange or feel uncomfortable
answering them. They may become self-conscious, thinking that the examiner may
consider them “crazy” if they were asked to participate or that the test does not apply to
them. In those situations the examiner should explain to the respondent that the test
assesses many different types of personality and emotional difficulties people have and
that it would be unlikely that respondents would identify themselves with all items. The
examiner should then encourage the respondents to continue completing the assessment
measures, reminding them of the confidentiality nature of their answers and the important
contribution they are making to the study.
The self-report measures are not difficult to answer but require that respondents be able
to think clearly about their typical behaviors and their subjective experience. If
respondents are feeling rushed or for any reason unable to concentrate while answering
the test, their answers may be unreliable. To reduce the possibility of this happening, the
assessment materials should be administered in a quiet, private, and well-lit room. Group
administrations (more than one person answering the assessment materials at the same
time and in the same room) are allowed and considered private if the respondents are
answering the questions on their own, with no one looking over their shoulders or giving
them opinions about how they should answer a particular question. Even if respondents
say that they have nothing to hide from their partners, family members, or friends, the
examiner must insist that the assessment materials be completed without anyone’s help or
interference. The examiner should then tell the respondents that, after they complete the
assessment materials, they are free to share the experience with anyone they chose to do
so.
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III.

Data Collection Sites

A.

Clinical Sample

Clinical subjects will be recruited through two substance abuse treatment facilities in
Brazil – the Pater-Aldeia Clinic and the Primeira Clínica Popular do Estado do Rio de
Janeiro. Contact with the program directors of these institutions was made by the primary
investigator, Cristina Magalhaes, and a written authorization for data collection was
obtained. Contact information for the substance abuse treatment facilities involved in this
study:
Renato Mussi
Clinica Pater-Aldeia
E-mail: rmussi@nitnet.com.br
Elen Fontes
Primeira Clínica Popular do Estado do Rio de Janeiro
E-mail: elenfontes@hotmail.com
B.

Non-Clinical Sample

Non-clinical subjects will be recruited through two churches in Brazil – the Igreja
Evangélica Congregacional and the Igreja Presbiteriana Betânia in Rio de Janeiro.
Contact with the leaders in charge of these congregations was made by the primary
investigator, Cristina Magalhaes, and a written authorization for data collection was
obtained. Contact information for the churches involved in this study:
Rev. Marcos Moura
Igreja Evangélica Congregacional
E-mail: mamoura@minasgas.com.br
Rev. Reginaldo Launé
Igreja Presbiteriana Betânia
E-mail: revregi@hotmail.com
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IV.

Selection of Participants

A.

Clinical Sample

Clinical participants should be selected based on the following criteria: (1) subject’s
willingness to participate; (2) being above eighteen years of age; and (3) being in
inpatient or outpatient treatment for alcohol/drug abuse or dependence. The clinical
sample should include a minimum of 50 subjects with a diagnosis of alcohol abuse or
dependence and 50 subjects with a diagnosis of drug abuse or dependence.
B.

Non-Clinical Sample

Non-clinical participants should be selected based on the following criteria: (1) subject’s
willingness to participate; (2) being above eighteen years of age; and (3) having no
history of substance abuse treatment. The non-clinical sample should include a minimum
of 50 subjects.
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IV.

Examiners

The examiners are:
1.
2.
3.
4.
5.

Monica Schaly
Vanda Guimarães
Elaine Guimarães
Vanete Ferreira
Rachel Ferreira

Monica Schaly is the research associate in charge of data collection in Brazil. She has a
Masters degree in mental health counseling from Florida Atlantic University and is a
licensed mental health counselor by the Florida Department of Health, with over 10 years
of clinical experience. She was provided with research protocol and was fully trained by
the primary investigator, Cristina Magalhaes, on all procedures for data collection.
In addition to administering the assessment materials to the participants, Ms. Schaly is
responsible for overseeing the implementation of the data collection procedures,
supervising the research assistants, and ensuring consistency of instrument administration
across examiners. The research assistants – Vanda Guimarães, Elaine Guimarães, Vanete
Ferreira and Rachel Ferreira – were also directly trained by the principal investigator and
will assist Ms. Schaly in all aspects of data collection.
The primary investigator and the examiners will hold a phone meeting once weekly to go
over any problems they may encounter during the previous week and decide on
procedure modifications if necessary.
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V.

The Role of the Examiner

A.

Recruitment: The examiner is responsible for explaining the purpose of the study
to potential participants and to obtain their voluntary consent in collaborating with
the project. The examiner is also responsible for explaining all procedures
involved, including the risks and benefits associated with their participation, and
their right to withdraw from the study at any time. The examiner should assure
potential participants that their answers will be kept confidential and those who
agree to participate will be asked to sign an Informed Consent Form. Before
asking participants to sign, they should be given time to read the Informed
Consent Form (or it should be read to them).

B.

Scheduling: Participants can complete the assessment materials immediately after
they agree to participate in the study (after recruitment) or schedule an
appointment to meet with the examiner at a later time or date - whichever will be
more convenient for the participant and less disruptive of the site’s regular
routine. The examiner is then responsible for discussing scheduling options with
the participant and arriving at a decision of when it would be the best time to
administer the assessment measures, based on the examiner’s availability and
room availability.

C.

Administration: The examiner is responsible for providing the participants with
an appropriate testing environment and the materials required for the completion
of the test, which include 2 sharpened black-lead pencils, an eraser, and all testing
forms contained in the assessment packet. For the purposes of this study, an
appropriate testing environment is defined as a quiet, private, and well-lit room,
with a table and a chair, or a chair with an attached writing surface, where the
respondent can comfortably complete the testing materials. The examiner is also
responsible for administering the different assessment instruments in the
appropriate order (counterbalanced*). The examiner should instruct the
participants on how to appropriately answer each instrument, by answering the
first 1 or 2 items of each measure with them to ensure that the instructions have
been understood. The examiner should let the participants know that he/she is
available to answer any questions during the assessment procedure and encourage
them to answer all items. In addition, the examiner is responsible for observing
the participants during the test administration and noting any behavior that may
indicate that they are completing the assessment packet in an unreliable manner.
If during administration of the instruments the examiner has reason to suspect that
a particular subject is answering the questions in a way that would render the
results unreliable, the answer sheets produced by this subject should be marked
with a question mark sign (?) at the top left corner, for later identification of
potentially unreliable protocols. The examiner should also write a brief
explanation of why he/she believes the protocol may be invalid. Before the full
administration is complete, the examiner should obtain the ICD-10 diagnosis from
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the participants’ medical file (for those participants that are receiving treatment
for substance abuse) and ask them to record it on the Demographic Questionnaire.
D.

Post-Administration: After the participants complete all instruments the
examiner should ask them to go over their own completed forms to see if they
missed answering any items. One issue that may come up during the
administration of the MCMI-III is the participants’ difficulty in deciding whether
an item is true or false for them. Some may object to statements with the words
always or never in them; and others may agree with parts of a statement while
disagreeing with the rest. In such cases, the examiner should agree with the
participant but encourage him or her to decide whether the statement is mostly
true or false. The examiner should maintain the position that it is important that
all items be answered, but if for any reason a participant refuses to answer an
item, the examiner should say to the participant “it is OK not to answer this item
if you don’t want to,” thank the person for participating in the study, and write the
word “refused” next to the unanswered item. The examiner should make sure all
forms completed by the same participant contain the same identification number
and are stapled together to facilitate data entry. Signed Informed Consent Forms
should be kept separate from completed assessment packets.

